<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "22: potential conflicts", fill: "#f6adc6"},
{source: "22: potential conflicts", target: "22: existing agreements", fill: "#f6adc6"},
{source: "22: existing agreements", target: "22: with certain", fill: "#f6adc6"},
{source: "22: with certain", target: "22: directors officers principal shareholders", fill: "#f6adc6"},
{source: "22: directors officers principal shareholders", target: "22: shareholders", fill: "#f6adc6"},
{source: "22: potential conflicts", target: "33: agreements", fill: "#f99"},
{source: "33: agreements", target: "33: provide us with", fill: "#f99"},
{source: "33: provide us with", target: "33: designate qualified successor physician owners", fill: "#f99"},
{source: "33: designate qualified successor physician owners", target: "33: professional corporations upon", fill: "#f99"},
{source: "33: professional corporations upon", target: "33: certain events there", fill: "#f99"},
{source: "33: certain events there", target: "33: enforce them under", fill: "#f99"},
{source: "33: enforce them under", target: "33: challenged by regulatory agencies", fill: "#f99"},
{source: "33: agreements", target: "51: treatment centers", fill: "#ffa089"},
{source: "51: treatment centers", target: "51: radiation oncologists", fill: "#ffa089"},
{source: "51: radiation oncologists", target: "51: provide professional services at", fill: "#ffa089"},
{source: "51: treatment centers", target: "82: significant", fill: "#eb4c42"},
{source: "82: significant", target: "82: treatment centers", fill: "#eb4c42"},
{source: "82: treatment centers", target: "82: concentrated", fill: "#eb4c42"},
{source: "82: concentrated", target: "82: particularly", fill: "#eb4c42"},
{source: "82: particularly", target: "82: us particularly sensitive", fill: "#eb4c42"},
{source: "82: us particularly sensitive", target: "82: regulatory economic", fill: "#eb4c42"},
{source: "82: regulatory economic", target: "82: conditions", fill: "#eb4c42"},
{source: "82: significant", target: "92: growth however will depend on several factors", fill: "#e25098"},
{source: "92: growth however will depend on several factors", target: "92: desirable locations", fill: "#e25098"},
{source: "92: desirable locations", target: "92: treatment centers", fill: "#e25098"},
{source: "92: treatment centers", target: "92: suitable markets", fill: "#e25098"},
{source: "92: suitable markets", target: "92: affiliate with", fill: "#e25098"},
{source: "92: affiliate with", target: "92: radiation oncologists", fill: "#e25098"},
{source: "92: radiation oncologists", target: "92: professionals", fill: "#e25098"},
{source: "92: professionals", target: "92: Contents ", fill: "#e25098"},
{source: "92: Contents ", target: "92: adequate financing", fill: "#e25098"},
{source: "92: adequate financing", target: "92: growth strategy", fill: "#e25098"},
{source: "92: growth strategy", target: "92: successfully", fill: "#e25098"},
{source: "92: successfully", target: "92: under applicable government", fill: "#e25098"},
{source: "92: under applicable government", target: "92: regulations", fill: "#e25098"},
{source: "92: growth however will depend on several factors", target: "100: additional treatment centers", fill: "#534b4f"},
{source: "100: additional treatment centers", target: "100: treatment centers", fill: "#534b4f"},
{source: "100: treatment centers", target: "100: successfully", fill: "#534b4f"},
{source: "100: successfully", target: "100: difficulty integrating", fill: "#534b4f"},
{source: "100: difficulty integrating", target: "100: operations", fill: "#534b4f"},
{source: "100: operations", target: "100: radiation oncologists", fill: "#534b4f"},
{source: "100: radiation oncologists", target: "100: key management personnel", fill: "#534b4f"},
{source: "100: key management personnel", target: "100: accounts receivable", fill: "#534b4f"},
{source: "100: accounts receivable", target: "100: treatment centers with unknown", fill: "#534b4f"},
{source: "100: treatment centers with unknown", target: "100: contingent liabilities", fill: "#534b4f"},
{source: "100: contingent liabilities", target: "100: liabilities", fill: "#534b4f"},
{source: "100: liabilities", target: "100: comply with healthcare laws", fill: "#534b4f"},
{source: "100: comply with healthcare laws", target: "100: regulations", fill: "#534b4f"},
{source: "100: regulations", target: "100: contract with thirdparty payors", fill: "#534b4f"},
{source: "100: contract with thirdparty payors", target: "100: attract patients", fill: "#534b4f"},
{source: "100: attract patients", target: "100: initial periods", fill: "#534b4f"},
{source: "100: additional treatment centers", target: "START_HERE", fill: "#534b4f"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Commercial and Professional Services</td>
    </tr>
    <tr>
      <td>Human Resource and Employment Services</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Diversified Financial Services</td>
    </tr>
    <tr>
      <td>Oil and Gas Storage and Transportation</td>
    </tr>
    <tr>
      <td>Oil and Gas Refining and Marketing and Transportation</td>
    </tr>
    <tr>
      <td>Transportation</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Electronic Equipment and Instruments</td>
    </tr>
    <tr>
      <td>Construction and Engineering</td>
    </tr>
    <tr>
      <td>Construction Materials</td>
    </tr>
    <tr>
      <td>Construction and Farm Machinery and Heavy Trucks</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Insurance</td>
    </tr>
    <tr>
      <td>Property and Casualty Insurance</td>
    </tr>
    <tr>
      <td>Life and Health Insurance</td>
    </tr>
    <tr>
      <td>Insurance Brokers</td>
    </tr>
    <tr>
      <td>Multi-line Insurance</td>
    </tr>
    <tr>
      <td>Housewares and Specialties</td>
    </tr>
    <tr>
      <td>Home Improvement Retail</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Economic</td>
    </tr>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Leadership</td>
    </tr>
    <tr>
      <td>Crime</td>
    </tr>
    <tr>
      <td>Humanitarian</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Consult</td>
    </tr>
    <tr>
      <td>Endorse</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Propose</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Promise policy support</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Grant</td>
    </tr>
    <tr>
      <td>Reward</td>
    </tr>
    <tr>
      <td>Empathize</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Reject</td>
    </tr>
    <tr>
      <td>Ask for protection</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Public_company">Public company</a></td>
      <td>A public company, publicly traded company, publicly held company, publicly listed company, or public limited company is a company whose ownership is organized via shares of stock which are intended to be freely traded on a stock exchange or in over-the-counter markets. A public (publicly traded) company can be listed on a stock exchange (listed company), which facilitates the trade of shares, or not (unlisted public company).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulation_of_therapeutic_goods">Regulation of therapeutic goods</a></td>
      <td>The regulation of therapeutic goods, defined as drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Cancer_Treatment_Centers_of_America">Cancer Treatment Centers of America</a></td>
      <td>Cancer Treatment Centers of America (CTCA), headquartered in Boca Raton, Florida, is a national, for-profit network of five comprehensive cancer care and research centers and three out patient care centers that serves cancer patients throughout the United States. \nCTCA was originally headquartered in Schaumburg, Illinois.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Residential_treatment_center">Residential treatment center</a></td>
      <td>A residential treatment center (RTC), sometimes called a rehab, is a live-in health care facility providing therapy for substance use disorders, mental illness, or other behavioral problems. Residential treatment may be considered the "last-ditch" approach to treating abnormal psychology or psychopathology.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Drug_rehabilitation">Drug rehabilitation</a></td>
      <td>Drug rehabilitation is the process of medical or psychotherapeutic treatment for dependency on psychoactive substances such as alcohol, prescription drugs, and street drugs such as cannabis, cocaine, heroin or amphetamines. The general intent is to enable the patient to confront substance dependence, if present, and stop substance misuse to avoid the psychological, legal, financial, social, and physical consequences that can be caused.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Promises_Treatment_Centers">Promises Treatment Centers</a></td>
      <td>Promises Treatment Centers were a for-profit provider of residential drug and alcohol rehabilitation with facilities in Malibu, California and West Los Angeles, California.  It was founded by Richard Rogg in 1989 and acquired by David Sack of Elements Behavioral Health in 2008.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Proton_therapy">Proton therapy</a></td>
      <td>In the field of medical treatment, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer. The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth, which results in minimal entry, exit, or scattered radiation dose to healthy nearby tissues.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/North_American_gambling_treatment_centers">North American gambling treatment centers</a></td>
      <td>North American gambling treatment centers are intended to treat gambling addiction.  In general, gambling addiction treatment is considered an add-on to other addiction treatments.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Passages_Malibu">Passages Malibu</a></td>
      <td>Passages Malibu Addiction Treatment Center, known as Passages Malibu, is a for-profit addiction treatment facility located in Malibu, California and founded by Pax and Chris Prentiss in 2001. Passages Ventura opened in 2009 in Port Hueneme, California.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Betty_Ford_Center">Betty Ford Center</a></td>
      <td>The Betty Ford Center (BFC) is a non-profit, residential treatment center for persons with substance dependence in Rancho Mirage, California. It offers inpatient, outpatient, and residential day treatment for alcohol and other drug addictions, as well as prevention and education programs for family and children.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Elevations_RTC">Elevations RTC</a></td>
      <td>Elevations RTC is a residential treatment center in Syracuse, Utah, for teens ages 13–18.  The facility was formerly known as Island View Residential Treatment Center until 2014, when it was acquired by Syracuse RTC, LLC, which does business as Elevations RTC. The Elevations campus is shared with Seven Stars and ViewPoint Center.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Poison_control_center">Poison control center</a></td>
      <td>A poison control center is a medical service that is able to provide immediate, free, and expert treatment advice and assistance over the telephone in case of exposure to poisonous or hazardous substances. Poison control centers answer questions about potential poisons in addition to providing treatment management advice about household products, medicines, pesticides, plants, bites and stings, food poisoning, and fumes.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Radiation_oncologist">Radiation oncologist</a></td>
      <td>A radiation oncologist is a specialist physician who uses ionizing radiation (such as megavoltage X-rays or radionuclides) in the treatment of cancer.  Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Radiation_therapy">Radiation therapy</a></td>
      <td>Radiation therapy or radiotherapy, often abbreviated RT, RTx, or XRT, is a therapy using ionizing radiation, generally provided as part of cancer treatment to control or kill malignant cells and normally delivered by a linear accelerator. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Oncology">Oncology</a></td>
      <td>Ontology is the branch of philosophy that studies concepts such as existence, being, becoming, and reality. It includes the questions of how entities are grouped into basic categories and which of these entities exist on the most fundamental level.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Radiation_therapist">Radiation therapist</a></td>
      <td>A radiation therapist, therapeutic radiographer or radiotherapist is an allied health professional who works in the field of radiation oncology. Radiation therapists plan and administer radiation treatments to cancer patients in most Western countries including the United Kingdom, Australia, most European countries, and Canada, where the minimum education requirement is often a baccalaureate degree or postgraduate degrees in radiation therapy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Radiation_treatment_planning">Radiation treatment planning</a></td>
      <td>In radiotherapy, radiation treatment planning (RTP) is the process in which a team consisting of radiation oncologists, radiation therapist, medical physicists and medical dosimetrists plan the appropriate external beam radiotherapy or internal brachytherapy treatment technique for a patient with cancer.\n\n\n== History ==\nIn the early days of radiotherapy planning was performed on 2D x-ray images, often by hand and with manual calculations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Hodgkin_lymphoma">Hodgkin lymphoma</a></td>
      <td>Hodgkin lymphoma (HL) is a type of lymphoma, in which cancer originates from a specific type of white blood cell called lymphocytes, where multinucleated Reed–Sternberg cells (RS cells) are present in the patient's lymph nodes. The condition was named after the English physician Thomas Hodgkin, who first described it in 1832.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Catherine_Nyongesa">Catherine Nyongesa</a></td>
      <td>Catherine Naliaka Nyongesa Watta (née Catherine Naliaka) (born in 1970), is a Kenyan physician and radiation oncologist, who is the founder, owner and chief executive of Texas Cancer Centre, in Nairobi, the capital and largest city in the country.\n\n\n== Background and education ==\nShe was born in Kenya, circa 1970.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/External_beam_radiotherapy">External beam radiotherapy</a></td>
      <td>External beam radiotherapy (EBRT)  is the most common form of radiotherapy (radiation therapy). The patient sits or lies on a couch and an external source of ionizing radiation is pointed at a particular part of the body.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/American_College_of_Radiology">American College of Radiology</a></td>
      <td>The American College of Radiology (ACR), founded in 1923, is a professional medical society representing nearly 40,000 diagnostic radiologists, radiation oncologists, interventional radiologists, nuclear medicine physicians and medical physicists.\nThe ACR has 54 chapters in the United States, Canada and the Council of Affiliated Regional Radiation Oncology Societies (CARROS).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Tumors_of_the_hematopoietic_and_lymphoid_tissues">Tumors of the hematopoietic and lymphoid tissues</a></td>
      <td>Tumors of the hematopoietic and lymphoid tissues (American English) or tumours of the haematopoietic and lymphoid tissues (British English) are tumors that affect the blood, bone marrow, lymph, and lymphatic system. Because these tissues are all intimately connected through both the circulatory system and the immune system, a disease affecting one will often affect the others as well, making myeloproliferation and lymphoproliferation (and thus the leukemias and the lymphomas) closely related and often overlapping problems.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulation">Regulation</a></td>
      <td>Regulation is the management of complex systems according to a set of rules and trends. In systems theory, these types of rules exist in various fields of biology and society, but the term has slightly different meanings according to context.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulation_A">Regulation A</a></td>
      <td>In the United States under the Securities Act of 1933, any offer to sell securities must either be registered with the United States Securities and Exchange Commission (SEC) or meet certain qualifications to exempt it from such registration. Regulation A (or Reg A) contains rules providing exemptions from the registration requirements, allowing some companies to use equity crowdfunding to offer and sell their securities without having to register the securities with the SEC. Regulation A offerings are intended to make access to capital possible for small and medium-sized companies that could not otherwise bear the costs of a normal SEC registration and to allow nonaccredited investors to participate in the offering.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Formula_One_regulations">Formula One regulations</a></td>
      <td>The numerous Formula One regulations, made and enforced by the FIA and later the FISA, have changed dramatically since the first Formula One World Championship in 1950. This article covers the current state of F1 technical and sporting regulations, as well as the history of the technical regulations since 1950.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulation_(European_Union)">Regulation (European Union)</a></td>
      <td>A regulation is a legal act of the European Union that becomes immediately enforceable as law in all member states simultaneously. Regulations can be distinguished from directives which, at least in principle, need to be transposed into national law.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Radio_regulation">Radio regulation</a></td>
      <td>Radio regulation refers to the regulation and licensing of radio in international law, by individual governments, and by municipalities.\n\n\n== International regulation ==\nThe International Telecommunication Union (ITU) is a specialized agency of the United Nations (UN) that is responsible for issues that concern information and communication technologies.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/New_York_Codes,_Rules_and_Regulations">New York Codes, Rules and Regulations</a></td>
      <td>The New York Codes, Rules and Regulations (NYCRR) contains New York state rules and regulations. The NYCRR is officially compiled by the New York State Department of State's Division of Administrative Rules.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Arithmetic">Arithmetic</a></td>
      <td>Arithmetic (from Ancient Greek  ἀριθμός (arithmós) 'number', and  τική [τέχνη] (tikḗ [tékhnē]) 'art, craft') is an elementary part of mathematics that consists of the study of the properties of the traditional operations on numbers—addition, subtraction, multiplication, division, exponentiation, and extraction of roots. In the 19th century, Italian mathematician Giuseppe Peano formalized arithmetic with his Peano axioms, which are highly important to the field of mathematical logic today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bitwise_operation">Bitwise operation</a></td>
      <td>In computer programming, a bitwise operation operates on a bit string, a bit array or a binary numeral (considered as a bit string) at the level of its individual bits. It is a fast and simple action, basic to the higher-level arithmetic operations and directly supported by the processor.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_Activities_Center">Special Activities Center</a></td>
      <td>The Special Activities Center (SAC) is a division of the Central Intelligence Agency responsible for covert operations and paramilitary operations. The unit was named Special Activities Division (SAD) prior to 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_management">Operations management</a></td>
      <td>Operations management is an area of management concerned with designing and controlling the process of production and redesigning business operations in the production of goods or services. It involves the responsibility of ensuring that business operations are efficient in terms of using as few resources as needed and effective in meeting customer requirements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_operations">Special operations</a></td>
      <td>Special operations (S.O.) are military activities conducted, according to NATO, by "specially designated, organized, selected, trained, and equipped forces using unconventional techniques and modes of employment". Special operations may include reconnaissance, unconventional warfare, and counter-terrorism actions, and are typically conducted by small groups of highly-trained personnel, emphasizing sufficiency, stealth, speed, and tactical coordination, commonly known as "special forces".</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>You <font color="blue">should <font color="blue">carefully</font></font> consider     the following risks, as well as the other information contained in this     10-K, including our <font color="blue">consolidated financial statements</font> and the related notes,     before investing in our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>Risks Related to Our Business          We <font color="blue"><font color="blue">depend on</font> <font color="blue">payments from</font> <font color="blue">government</font></font> <font color="blue">Medicare and Medicaid </font>programs for a     <font color="blue"><font color="blue">significant</font> amount</font> of our revenue and our business could be <font color="blue">materially</font>     <font color="blue">harmed by</font> any changes that result in <font color="blue"><font color="blue">reimbursement</font> reductions</font></td>
    </tr>
    <tr>
      <td>We estimate that     approximately 55prca, 53prca and 50prca of our <font color="blue"><font color="blue">net patient service</font> revenue</font> for 2003,     2004  and  2005, <font color="blue">respectively</font>, consisted of <font color="blue">payments from</font> Medicare and     Medicaid</td>
    </tr>
    <tr>
      <td>These  <font color="blue">government</font>  programs  <font color="blue">generally</font>  reimburse  us  on a     fee-for-service basis <font color="blue">based on</font> predetermined <font color="blue">government</font> <font color="blue">reimbursement</font> rate     schedules</td>
    </tr>
    <tr>
      <td>As a result of these <font color="blue">reimbursement</font> schedules, we are limited in     the amount we can record as revenue for our services from these <font color="blue">government</font>     programs</td>
    </tr>
    <tr>
      <td>If our operating costs increase, we will not be able to recover     these  costs  from <font color="blue">government</font> payors</td>
    </tr>
    <tr>
      <td>Medicare <font color="blue">reimbursement</font> rates are     determined by a <font color="blue">formula which</font> takes <font color="blue">into account</font> an <font color="blue">industry wide <font color="blue">conversion</font></font>     factor (CF) which may change on an <font color="blue">annual basis</font></td>
    </tr>
    <tr>
      <td>In 2003, the CF increased     by 1dtta6prca; in 2004, it increased by 1dtta5prca; and in 2005, the <font color="blue">rate increased</font> an     <font color="blue">additional</font> 1dtta5prca and in 2006 the CF will not change from the 2005 level</td>
    </tr>
    <tr>
      <td>The     net result of these changes in the <font color="blue">conversion</font> factor in the <font color="blue">past several</font>     years has not had a <font color="blue"><font color="blue">significant</font> <font color="blue">impact on</font></font> our business</td>
    </tr>
    <tr>
      <td>There can be no     assurance that increases <font color="blue">will continue</font>, scheduled increases will materialize     or <font color="blue">decreases will</font> not occur in the future</td>
    </tr>
    <tr>
      <td>Changes in the Medicare, Medicaid     or similar <font color="blue">government</font> programs that limit or reduce the amounts paid to us     for any of our services or <font color="blue">specific procedures could</font> cause our revenue and     <font color="blue">profitability</font> to decline</td>
    </tr>
    <tr>
      <td>If  <font color="blue">payments by <font color="blue">managed care <font color="blue">organizations</font></font></font> and other <font color="blue">commercial payors</font>     decrease, our revenue and <font color="blue">profitability</font> could be <font color="blue"><font color="blue">adversely</font> affected</font></td>
    </tr>
    <tr>
      <td>We estimate that approximately 43prca, 46prca and 47prca of our <font color="blue">net patient service</font>     revenue for 2003, 2004 and 2005, <font color="blue">respectively</font>, was <font color="blue"><font color="blue">derived from</font> commercial</font>     <font color="blue">payors such as <font color="blue">managed care <font color="blue">organizations</font></font></font> and <font color="blue">private health insurance</font>     programs</td>
    </tr>
    <tr>
      <td>These <font color="blue">commercial payors</font> <font color="blue">generally</font> pay us for the services rendered     to  an  insured  patient  <font color="blue"><font color="blue">based upon</font> predetermined rates</font></td>
    </tr>
    <tr>
      <td>While <font color="blue">commercial payor rates</font> are <font color="blue">generally</font> higher than <font color="blue">government</font>     program <font color="blue">reimbursement</font> rates, <font color="blue">commercial payor rates</font> are based in part on     Medicare <font color="blue">reimbursement</font> rates and when Medicare rates are lowered, commercial     rates are <font color="blue">often lowered as well</font></td>
    </tr>
    <tr>
      <td>If <font color="blue">managed care <font color="blue">organizations</font></font> and other     <font color="blue">private insurers reduce</font> their rates or we experience a <font color="blue">significant</font> shift in     our  revenue  <font color="blue">mix toward <font color="blue">additional</font> managed care payors</font> or Medicare or     Medicaid <font color="blue">reimbursement</font>s, then our revenue and <font color="blue">profitability</font> will decline and     our operating <font color="blue">margins will</font> be reduced</td>
    </tr>
    <tr>
      <td>Any <font color="blue">inability</font> to maintain suitable     financial <font color="blue">arrangements</font> with <font color="blue">commercial payors</font> could have a material adverse     <font color="blue">impact on</font> our business</td>
    </tr>
    <tr>
      <td>We  have <font color="blue">potential conflicts</font> of interest relating to our related party     <font color="blue"><font color="blue">transaction</font>s which <font color="blue">could harm</font></font> our business</td>
    </tr>
    <tr>
      <td>We have <font color="blue">potential conflicts</font> of interest relating to <font color="blue">existing <font color="blue"><font color="blue">agreement</font>s</font></font> we     have  <font color="blue">with certain</font> of our <font color="blue">directors</font>, officers, principal <font color="blue"><font color="blue">shareholder</font>s</font>,     <font color="blue"><font color="blue">shareholder</font>s</font> and employees</td>
    </tr>
    <tr>
      <td>In 2003, 2004 and 2005 we paid an aggregate of     dlra6dtta0 million, dlra8dtta1 million and dlra7dtta3 million, <font color="blue">respectively</font> under our related     <font color="blue">party <font color="blue"><font color="blue">agreement</font>s</font></font> and we received dlra21dtta8 million, dlra26dtta7 million and dlra24dtta8     million, <font color="blue">respectively</font> pursuant to our <font color="blue"><font color="blue">administrative</font> service <font color="blue"><font color="blue">agreement</font>s</font> with</font>     related parties</td>
    </tr>
    <tr>
      <td><font color="blue">Potential </font>conflicts of interest can exist if a related     party  director  or  officer has to make a decision that has <font color="blue">different</font>     <font color="blue">implications</font> for us and the related party</td>
    </tr>
    <tr>
      <td>If a dispute arises in <font color="blue">connection</font> with any of these <font color="blue"><font color="blue">agreement</font>s</font>, if not     resolved  <font color="blue">satisfactorily</font>  to  us,  our business could be harmed</td>
    </tr>
    <tr>
      <td><font color="blue">These     </font><font color="blue"><font color="blue">agreement</font>s</font> include our:           •   <font color="blue">administrative</font> services <font color="blue"><font color="blue">agreement</font>s</font> with <font color="blue">professional</font> <font color="blue"><font color="blue">corporation</font>s</font> that     are owned by certain of our <font color="blue">directors</font>, officers and principal <font color="blue"><font color="blue">shareholder</font>s</font>;           •   leases we have <font color="blue">entered into with entities</font> owned by certain of our     <font color="blue">directors</font>, officers, and principal <font color="blue"><font color="blue">shareholder</font>s</font>; and           •   <font color="blue">medical malpractice insurance which</font> we acquire from an entity owned by     certain of our <font color="blue">directors</font>, officers, and principal <font color="blue"><font color="blue">shareholder</font>s</font></td>
    </tr>
    <tr>
      <td>25     ______________________________________________________________________    [46]Table of <font color="blue">Contents       </font>In Maryland, Massachusetts, Nevada, New York and North Carolina, we have     <font color="blue">administrative</font> services <font color="blue"><font color="blue">agreement</font>s</font> with <font color="blue">professional</font> <font color="blue"><font color="blue">corporation</font>s</font> that are     owned by certain of our <font color="blue">directors</font>, officers and principal <font color="blue"><font color="blue">shareholder</font>s</font></td>
    </tr>
    <tr>
      <td>Michael J Katin, MD, a director, is a licensed physician in the states of     Nevada and North Carolina and we have <font color="blue">administrative</font> services <font color="blue"><font color="blue">agreement</font>s</font>     with his <font color="blue">professional</font> <font color="blue"><font color="blue">corporation</font>s</font> in these states</td>
    </tr>
    <tr>
      <td>In the state of New     York, our Chairman, Howard M Sheridan, MD, our Chief Executive Officer     and President, Daniel E Dosoretz, MD, our <font color="blue">Medical Director</font>, James H     Rubenstein,  MD  and  Dr</td>
    </tr>
    <tr>
      <td>Katin, are <font color="blue">licensed physicians</font> and we have     <font color="blue">administrative</font> services <font color="blue"><font color="blue">agreement</font>s</font> with their <font color="blue">professional</font> <font color="blue">corporation</font></td>
    </tr>
    <tr>
      <td>Additionally, Dr</td>
    </tr>
    <tr>
      <td>Katin, a principal <font color="blue">shareholder</font>, is a licensed physician in     the state <font color="blue">of Maryland </font>and we have an <font color="blue">administrative</font> services <font color="blue">agreement</font> with     his  <font color="blue">professional</font>  <font color="blue">corporation</font> in this state</td>
    </tr>
    <tr>
      <td>While we have transition     <font color="blue"><font color="blue">agreement</font>s</font> in place in all states except New York that <font color="blue">provide us with</font> the     ability to <font color="blue">designate qualified successor physician owners</font> of the shares held     by  the  physician  owners of these <font color="blue">professional</font> <font color="blue"><font color="blue">corporation</font>s</font> upon the     occurrence of certain events, there can be no assurance that we will be able     to <font color="blue">enforce them under</font> the laws of the respective states or that they will     not be <font color="blue">challenged by <font color="blue">regulatory</font> agencies</font></td>
    </tr>
    <tr>
      <td><font color="blue">Potential </font>conflicts of interest     may arise in <font color="blue">connection</font> with the <font color="blue">administrative</font> services <font color="blue"><font color="blue">agreement</font>s</font> that may     have  <font color="blue">materially</font>  <font color="blue">different</font>  <font color="blue">implications</font>  for us and the <font color="blue">professional</font>     <font color="blue"><font color="blue">corporation</font>s</font> and there can be no assurance that it will not harm us</td>
    </tr>
    <tr>
      <td>For     example, we are <font color="blue">generally</font> paid a fixed annual fee on a <font color="blue">monthly basis by</font> the     <font color="blue">professional</font> <font color="blue"><font color="blue">corporation</font>s</font> for our services, which are <font color="blue">generally</font> subject to     <font color="blue">renegotiation on</font> an <font color="blue">annual basis</font></td>
    </tr>
    <tr>
      <td>We may be unable to <font color="blue">renegotiate</font> acceptable     fees, in <font color="blue">which event</font> many of the <font color="blue">administrative</font> services <font color="blue"><font color="blue">agreement</font>s</font> provide     for  binding  <font color="blue">arbitration</font></td>
    </tr>
    <tr>
      <td>If we are <font color="blue">unsuccessful</font> in <font color="blue">renegotiations</font> or     <font color="blue">arbitration</font> this <font color="blue">could negatively impact</font> our operating margins or result in     the <font color="blue">termination</font> of our <font color="blue">administrative</font> services <font color="blue"><font color="blue">agreement</font>s</font></td>
    </tr>
    <tr>
      <td>Additionally, we lease 13 of our <font color="blue">properties from ownership groups</font> that     consist of certain of our <font color="blue">directors</font>, officers, principal <font color="blue"><font color="blue">shareholder</font>s</font>,     <font color="blue"><font color="blue">shareholder</font>s</font> and employees</td>
    </tr>
    <tr>
      <td>Our lease for the <font color="blue">Broadway </font>office in Fort Myers,     Florida is on a month-to-month basis and there can be no assurance that it     <font color="blue">will continue</font> in the future</td>
    </tr>
    <tr>
      <td>We may be unable to <font color="blue">renegotiate</font> these leases     when they come up for <font color="blue">renewal on terms</font> acceptable to us, if at all</td>
    </tr>
    <tr>
      <td>In October 2003, we replaced our existing third-party medical malpractice     <font color="blue"><font color="blue">insurance coverage</font> with coverage</font> we obtained from a newly-formed insurance     entity,  which  is owned <font color="blue">by physicians</font> including Drs</td>
    </tr>
    <tr>
      <td>We renewed this coverage in October 2004 and in     October 2005 which was <font color="blue">approved by</font> the <font color="blue">audit committee</font></td>
    </tr>
    <tr>
      <td>We may be unable to     <font color="blue">renegotiate</font> this <font color="blue">coverage at</font> acceptable rates and <font color="blue">comparable coverage may</font>     not  be  available  from  third-party  insurance  companies</td>
    </tr>
    <tr>
      <td>If we are     <font color="blue">unsuccessful</font> in renewing our <font color="blue">malpractice <font color="blue">insurance coverage</font></font>, we may not be     able to continue to operate without being exposed to substantial risks of     claims being made <font color="blue">against us</font> for <font color="blue">damage awards</font> we are unable to pay</td>
    </tr>
    <tr>
      <td>All  <font color="blue"><font color="blue">transaction</font>s between us</font> and any related party after our June 2004     <font color="blue">initial public offering</font> are subject to <font color="blue">approval by</font> the <font color="blue">audit committee</font> and     <font color="blue">disputes will</font> be <font color="blue">handled by</font> the <font color="blue">audit committee</font></td>
    </tr>
    <tr>
      <td>There can be no assurance     that the above or any <font color="blue">future conflicts</font> of interest will be resolved in our     favor</td>
    </tr>
    <tr>
      <td>If not resolved, such conflicts <font color="blue">could harm</font> our business</td>
    </tr>
    <tr>
      <td>In certain states we <font color="blue">depend on</font> <font color="blue">administrative</font> services <font color="blue"><font color="blue">agreement</font>s</font> with     <font color="blue">professional</font>   <font color="blue"><font color="blue">corporation</font>s</font>,   including  related  party  <font color="blue">professional</font>     <font color="blue"><font color="blue">corporation</font>s</font>, and if we are unable to continue to <font color="blue"><font color="blue">enter into</font> them</font> or they     are terminated, we could be <font color="blue">materially</font> harmed</td>
    </tr>
    <tr>
      <td>Certain states, including Alabama, California, Maryland, Massachusetts,     Nevada,  New  York  and North Carolina, have <font color="blue">laws prohibiting</font> business     <font color="blue"><font color="blue">corporation</font>s</font> from <font color="blue">employing physicians</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue"><font color="blue">treatment center</font>s</font> in Alabama,     Massachusetts,  Nevada,  New  York and North Carolina, operate through     <font color="blue">administrative</font> services <font color="blue"><font color="blue">agreement</font>s</font> with <font color="blue">professional</font> <font color="blue"><font color="blue">corporation</font>s</font> that     employ the <font color="blue">radiation <font color="blue">oncologists</font></font> who provide <font color="blue">professional</font> services at the     <font color="blue"><font color="blue">treatment center</font>s</font> in those states</td>
    </tr>
    <tr>
      <td>In 2003, 2004 and 2005, dlra35dtta1 million,     dlra45dtta8 million and dlra62dtta2 million, <font color="blue">respectively</font>, of our <font color="blue">net patient service</font>     revenue was <font color="blue">derived from</font> <font color="blue">administrative</font> services <font color="blue"><font color="blue">agreement</font>s</font>, as opposed to     dlra96dtta0 million, dlra117dtta9 million and dlra155dtta4 million from all of our other     centers</td>
    </tr>
    <tr>
      <td>The <font color="blue">professional</font> <font color="blue"><font color="blue">corporation</font>s</font> in these states are currently owned     by certain of our <font color="blue">directors</font>, officers and principal <font color="blue"><font color="blue">shareholder</font>s</font>, who are     licensed to <font color="blue">practice medicine</font> in those states</td>
    </tr>
    <tr>
      <td>As we <font color="blue">enter into</font> new states     that will require an <font color="blue">administrative</font> services <font color="blue">agreement</font>, there can be no     assurance that a related party <font color="blue">professional</font> <font color="blue">corporation</font>, or any <font color="blue">professional</font>     <font color="blue">corporation</font>,  will  be willing or able to <font color="blue">enter into</font> an <font color="blue">administrative</font>     services <font color="blue">agreement</font></td>
    </tr>
    <tr>
      <td>Furthermore, if we <font color="blue">enter into</font> an <font color="blue">administrative</font> services     <font color="blue">agreement</font>  with an <font color="blue">unrelated party there could</font> be an <font color="blue">increased risk</font> of     <font color="blue">differences</font> arising or future <font color="blue">termination</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot assure</font> you that a     <font color="blue">professional</font> <font color="blue">corporation</font> will not seek to terminate an <font color="blue">agreement</font> with us on     the  basis  that it violates the applicable state <font color="blue">laws prohibiting</font> the     <font color="blue">corporate practice</font> of medicine or any other <font color="blue">basis nor</font> can we assure you that     <font color="blue">government</font>al <font color="blue">authorities</font> in those states will not seek <font color="blue">termination</font> of these     <font color="blue"><font color="blue">arrangements</font> on</font> the <font color="blue">same basis</font></td>
    </tr>
    <tr>
      <td>While we have not been subject to such     <font color="blue">proceedings</font>  in  the  past,  nor  are  we <font color="blue">currently aware</font> of any other     <font color="blue"><font color="blue">corporation</font>s</font> that are subject to such <font color="blue">proceedings</font>, we could be <font color="blue">materially</font>     harmed  if  any  state  <font color="blue">government</font>al  <font color="blue">authorities</font>  or the <font color="blue">professional</font>     <font color="blue"><font color="blue">corporation</font>s</font> with which we have an <font color="blue">administrative</font> services <font color="blue">agreement</font> were to     succeed in such a <font color="blue">termination</font></td>
    </tr>
    <tr>
      <td>26     ______________________________________________________________________    [47]Table of <font color="blue">Contents       </font>We  <font color="blue"><font color="blue">depend on</font> recruiting</font> and retaining <font color="blue">radiation <font color="blue">oncologists</font></font> and other     qualified  healthcare <font color="blue">professional</font>s for our success and our ability to     enforce the non-<font color="blue">competition</font> covenants with <font color="blue">radiation <font color="blue">oncologists</font></font></td>
    </tr>
    <tr>
      <td>Our success is <font color="blue">dependent upon</font> our <font color="blue">continuing ability</font> to recruit, train and     retain or <font color="blue">affiliate with</font> <font color="blue">radiation <font color="blue">oncologists</font></font>, physicists, dosimetrists,     <font color="blue">radiation therapists</font> and <font color="blue">medical technicians</font></td>
    </tr>
    <tr>
      <td>While there is currently a     <font color="blue">national shortage</font> of these healthcare <font color="blue">professional</font>s, we have not experienced     <font color="blue">significant</font>  problems  attracting  and  retaining  key  personnel  and     <font color="blue">professional</font>s in the <font color="blue">recent past</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">face <font color="blue">competition</font></font> for <font color="blue">such personnel</font>     from  other  healthcare providers, research and <font color="blue">academic institutions</font>,     <font color="blue">government</font> entities and other <font color="blue">organizations</font></td>
    </tr>
    <tr>
      <td>In the event we are unable to     recruit and retain these <font color="blue">professional</font>s, such shortages could have a material     adverse effect on our ability to grow</td>
    </tr>
    <tr>
      <td>Additionally, many of our senior     <font color="blue">radiation <font color="blue">oncologists</font></font>, due to their <font color="blue">reputations</font> and experience, are very     important in the <font color="blue">recruitment</font> and <font color="blue">education</font> of <font color="blue">radiation <font color="blue">oncologists</font></font></td>
    </tr>
    <tr>
      <td>All of our <font color="blue">radiation <font color="blue">oncologists</font></font> except eight are employed under <font color="blue">employment</font>     <font color="blue"><font color="blue">agreement</font>s</font>  which,  among other provisions, provide that the radiation     <font color="blue">oncologists</font> will not <font color="blue">compete with us</font> (or the <font color="blue">professional</font> <font color="blue"><font color="blue">corporation</font>s</font>     <font color="blue">contracting with us</font>) for a period of time after <font color="blue">employment</font> terminates</td>
    </tr>
    <tr>
      <td><font color="blue">Such     </font>covenants not to compete are enforced to <font color="blue">varying degrees from</font> state to     state</td>
    </tr>
    <tr>
      <td>In most states, a covenant not to <font color="blue">compete will</font> be <font color="blue">enforced only</font> to     the extent that it is <font color="blue">necessary</font> to protect the legitimate business interest     of the <font color="blue">party seeking <font color="blue">enforcement</font></font>, that it does not <font color="blue">unreasonably restrain</font> the     <font color="blue">party against whom <font color="blue">enforcement</font></font> is sought and that it is not contrary to the     <font color="blue">public interest</font></td>
    </tr>
    <tr>
      <td>This de<font color="blue">termination</font> is made <font color="blue">based upon</font> all the facts and     <font color="blue">circumstances</font> of the <font color="blue">specific case at</font> the time <font color="blue">enforcement</font> is sought</td>
    </tr>
    <tr>
      <td>It is     <font color="blue">unclear whether</font> our interests under our <font color="blue">administrative</font> services <font color="blue"><font color="blue">agreement</font>s</font>     will be viewed <font color="blue">by courts as</font> the type of protected business interest that     would  permit  us  or  the  <font color="blue">professional</font>  <font color="blue"><font color="blue">corporation</font>s</font>  to  enforce  a     non-<font color="blue">competition</font>  <font color="blue">covenant against</font> the <font color="blue">radiation <font color="blue">oncologists</font></font></td>
    </tr>
    <tr>
      <td>Since our     <font color="blue">success depends</font> in substantial part on our ability to preserve the business     of our <font color="blue">radiation <font color="blue">oncologists</font></font>, a de<font color="blue">termination</font> that these <font color="blue">provisions will</font> not     be <font color="blue">enforced could</font> have a material adverse effect on us</td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on</font> our <font color="blue">senior <font color="blue">management</font></font> and we may be <font color="blue">materially</font> harmed if we     lose any member of our <font color="blue">senior <font color="blue">management</font></font></td>
    </tr>
    <tr>
      <td>We are <font color="blue">dependent upon</font> the services of our <font color="blue">senior <font color="blue">management</font></font>, especially     Dr</td>
    </tr>
    <tr>
      <td>Dosoretz, our Chief Executive Officer and President, and Dr</td>
    </tr>
    <tr>
      <td>Rubenstein,     our <font color="blue">Medical Director</font></td>
    </tr>
    <tr>
      <td>We have entered into executive <font color="blue">employment</font> <font color="blue"><font color="blue">agreement</font>s</font>     with  Drs</td>
    </tr>
    <tr>
      <td>The <font color="blue">initial term</font> of the <font color="blue">employment</font>     <font color="blue"><font color="blue">agreement</font>s</font> is <font color="blue">three years</font> and they <font color="blue">renew automatically</font> for <font color="blue">successive two</font>     year terms unless 120 days prior notice is <font color="blue">given by either party</font></td>
    </tr>
    <tr>
      <td><font color="blue">Because     </font>these members of our <font color="blue">senior <font color="blue">management</font></font> team have <font color="blue">been with us</font> for over 15     years and have <font color="blue">contributed greatly</font> to our growth, their <font color="blue">services would</font> be     very <font color="blue">difficult</font>, time consuming and costly to replace</td>
    </tr>
    <tr>
      <td>We carry key-man life     <font color="blue">insurance on</font> these <font color="blue">individuals</font></td>
    </tr>
    <tr>
      <td>The loss of <font color="blue">key <font color="blue">management</font> personnel</font> or our     <font color="blue">inability</font> to attract and retain <font color="blue">qualified <font color="blue">management</font> personnel could</font> have a     material adverse effect on us</td>
    </tr>
    <tr>
      <td>A <font color="blue">decision by</font> any of these <font color="blue">individuals</font> to     leave our employ, to <font color="blue">compete with us</font> or to reduce his <font color="blue">involvement on</font> our     behalf or as to any <font color="blue">professional</font> <font color="blue">corporation</font> they have an interest in and to     which we provide <font color="blue">administrative</font> services, would have a material adverse     effect on our business</td>
    </tr>
    <tr>
      <td>A <font color="blue">significant</font> number of our <font color="blue"><font color="blue">treatment center</font>s</font> are <font color="blue">concentrated</font> in certain     states, <font color="blue">particularly</font> Florida, which makes us <font color="blue">particularly</font> sensitive to     <font color="blue">regulatory</font>, economic and other <font color="blue">conditions</font> in those states</td>
    </tr>
    <tr>
      <td>Our Florida <font color="blue"><font color="blue">treatment center</font>s</font> accounted for approximately 68prca, 64prca and 57prca     of  our  total  revenues during 2003, 2004 and 2005, <font color="blue">respectively</font></td>
    </tr>
    <tr>
      <td>Our     <font color="blue"><font color="blue">treatment center</font>s</font> are also <font color="blue">concentrated</font> in the states of Nevada, <font color="blue">New York     </font>and North Carolina, none of <font color="blue">which individually currently account</font> for more     than  15prca  of  our  <font color="blue">total revenues</font>, but in the <font color="blue">aggregate accounted</font> for     approximately 26prca, 23prca and 23prca of our <font color="blue">total revenues</font> in 2003, 2004 and 2005,     <font color="blue">respectively</font></td>
    </tr>
    <tr>
      <td>If  our <font color="blue"><font color="blue">treatment center</font>s</font> in these states are <font color="blue">adversely</font>     affected  by changes in <font color="blue">regulatory</font>, economic and other <font color="blue">conditions</font>, our     revenue and <font color="blue">profitability</font> may decline</td>
    </tr>
    <tr>
      <td>In particular, we <font color="blue">employ radiation</font>     <font color="blue">oncologists</font> and other <font color="blue">physicians at</font> our Florida <font color="blue"><font color="blue">treatment center</font>s</font> and if we     are  restricted  or  prohibited  from  doing so in the future it could     <font color="blue">significant</font>ly harm our business</td>
    </tr>
    <tr>
      <td>Our <font color="blue"><font color="blue">growth strategy</font> depends</font> in part on our ability to acquire and develop     <font color="blue">additional</font> <font color="blue"><font color="blue">treatment center</font>s</font> on favorable terms</td>
    </tr>
    <tr>
      <td>If we are unable to do so,     our  <font color="blue">future growth could</font> be limited and our operating results could be     <font color="blue"><font color="blue">adversely</font> affected</font></td>
    </tr>
    <tr>
      <td>We may be unable to identify, negotiate and complete <font color="blue">suitable <font color="blue">acquisition</font></font>     and <font color="blue"><font color="blue">development</font> opportunities on reasonable terms</font></td>
    </tr>
    <tr>
      <td>We expect to continue to add     <font color="blue">additional</font> <font color="blue"><font color="blue">treatment center</font>s</font> in our existing and <font color="blue">new local markets</font></td>
    </tr>
    <tr>
      <td>Our     growth, however, will <font color="blue">depend on</font> several factors, including:           •   our ability to obtain <font color="blue">desirable locations</font> for <font color="blue"><font color="blue">treatment center</font>s</font> in     <font color="blue">suitable markets</font>;           •   our ability to identify, recruit and retain or <font color="blue">affiliate with</font> a     sufficient number of <font color="blue">radiation <font color="blue">oncologists</font></font> and other healthcare     <font color="blue">professional</font>s;                                           27     ______________________________________________________________________    [48]Table of <font color="blue">Contents       </font>  •   our ability to obtain <font color="blue">adequate financing</font> to fund our <font color="blue">growth strategy</font>;     and           •   our ability to <font color="blue">successfully</font> operate under applicable <font color="blue">government</font>     <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>If our <font color="blue">growth strategy</font> does not succeed, our business could be harmed</td>
    </tr>
    <tr>
      <td>We  may  not  be able to grow our business <font color="blue">effectively</font> or <font color="blue">successfully</font>     implement our growth plans if we are unable to <font color="blue">recruit <font color="blue">additional</font> <font color="blue">management</font></font>     and other personnel</td>
    </tr>
    <tr>
      <td>Our ability to continue to grow our business <font color="blue">effectively</font> and <font color="blue">successfully</font>     implement  our <font color="blue">growth strategy</font> is highly <font color="blue">dependent upon</font> our ability to     attract and retain <font color="blue">qualified <font color="blue">management</font> employees</font> and other <font color="blue">key employees</font></td>
    </tr>
    <tr>
      <td>As such, there can be no assurance     that we will be able to identify and retain the <font color="blue">key personnel</font> that may be     <font color="blue">necessary</font> to grow our business <font color="blue">effectively</font> or <font color="blue">successfully</font> implement our     <font color="blue">growth strategy</font></td>
    </tr>
    <tr>
      <td>If we are unable to attract and retain <font color="blue">talented personnel</font>     it <font color="blue">could limit</font> our ability to grow our business</td>
    </tr>
    <tr>
      <td>We  may  <font color="blue">encounter numerous</font> business risks in acquiring and developing     <font color="blue">additional</font>  treatment  centers,  and may have <font color="blue">difficult</font>y operating and     <font color="blue">integrating</font> those <font color="blue"><font color="blue">treatment center</font>s</font></td>
    </tr>
    <tr>
      <td>If we acquire or develop <font color="blue">additional</font> <font color="blue"><font color="blue">treatment center</font>s</font>, we may:           •   be unable to <font color="blue">successfully</font> operate the <font color="blue"><font color="blue">treatment center</font>s</font>;           •   have <font color="blue">difficult</font>y <font color="blue">integrating</font> their <font color="blue">operations</font> and personnel;           •   be unable to retain <font color="blue">radiation <font color="blue">oncologists</font></font> or <font color="blue">key <font color="blue">management</font> personnel</font>;           •   be unable to collect the <font color="blue">accounts receivable</font> of an acquired treatment     center;           •   acquire <font color="blue"><font color="blue">treatment center</font>s</font> with unknown or <font color="blue">contingent <font color="blue">liabilities</font></font>,     including <font color="blue">liabilities</font> for failure to <font color="blue"><font color="blue">comply with</font> healthcare laws</font> and     <font color="blue">regulations</font>;           •   be unable to contract with third-party payors or <font color="blue">attract patients</font> to     our <font color="blue"><font color="blue">treatment center</font>s</font>; or           •   experience losses and lower gross revenues and operating margins     during the <font color="blue">initial periods</font> of operating our newly-developed treatment     centers</td>
    </tr>
    <tr>
      <td>Furthermore, <font color="blue">integrating</font> a <font color="blue">new <font color="blue">treatment center</font> could</font> be expensive and time     consuming,  and  could  disrupt  our ongoing business and distract our     <font color="blue">management</font> and other <font color="blue">key personnel</font></td>
    </tr>
    <tr>
      <td>We currently plan to develop new <font color="blue"><font color="blue">treatment center</font>s</font> in existing and new local     markets</td>
    </tr>
    <tr>
      <td>We  may  not  be  able  to <font color="blue">structure economically beneficial</font>     <font color="blue">arrangements</font> in new states as a result of these <font color="blue">respective healthcare laws</font>     or  otherwise</td>
    </tr>
    <tr>
      <td>If these plans change for any reason or the anticipated     schedules for opening and costs of <font color="blue">development</font> are <font color="blue">revised by us</font>, we may be     <font color="blue">negatively impacted</font></td>
    </tr>
    <tr>
      <td>We may not be able to integrate and staff these new     <font color="blue"><font color="blue">treatment center</font>s</font></td>
    </tr>
    <tr>
      <td>There can be no assurance that these planned treatment     <font color="blue">centers will</font> be completed or that, if developed, will achieve sufficient     <font color="blue">patient volume</font> to generate positive operating margins</td>
    </tr>
    <tr>
      <td>If we are unable to     timely and <font color="blue">efficiently integrate</font> an acquired or newly-developed treatment     center, our business <font color="blue">could suffer</font></td>
    </tr>
    <tr>
      <td>We may be subject to actions for false claims if we do not <font color="blue">comply with</font>     <font color="blue">government</font> coding and <font color="blue"><font color="blue">billing rules</font> which <font color="blue">could harm</font></font> our business</td>
    </tr>
    <tr>
      <td>If  we fail to <font color="blue">comply with</font> federal and state documentation, coding and     <font color="blue">billing rules</font>, we could be subject to criminal and/or civil penalties, loss     of licenses and <font color="blue">exclusion from</font> the <font color="blue">Medicare and Medicaid </font>programs, which     <font color="blue"><font color="blue">could harm</font> us</font></td>
    </tr>
    <tr>
      <td>We estimate that approximately 55prca, 53prca and 50prca of our net     <font color="blue">patient service revenue</font> for 2003, 2004 and 2005, <font color="blue">respectively</font>, consisted of     <font color="blue">payments from</font> <font color="blue">Medicare and Medicaid </font>programs</td>
    </tr>
    <tr>
      <td>In billing for our services to     third-party payors, we must follow complex documentation, coding and billing     rules</td>
    </tr>
    <tr>
      <td>These  rules  are  based  on federal and state laws, rules and     <font color="blue">regulations</font>, various <font color="blue">government</font> pronouncements, and <font color="blue">on industry practice</font></td>
    </tr>
    <tr>
      <td>Failure to follow these rules could result in potential criminal or civil     <font color="blue">liability</font>  under  the  federal False Claims Act, under which extensive     <font color="blue">financial penalties</font> can be imposed</td>
    </tr>
    <tr>
      <td>It <font color="blue">could further</font> result in criminal     <font color="blue">liability</font> under various federal and state <font color="blue">criminal statutes</font></td>
    </tr>
    <tr>
      <td>We submit     thousands of claims for Medicare and other payments and there can be no     assurance that there have <font color="blue">been no errors</font></td>
    </tr>
    <tr>
      <td>While we <font color="blue">carefully</font> and regularly     review  our documentation, coding and <font color="blue">billing practices as</font> part of our     <font color="blue">compliance program</font>, the rules are <font color="blue">frequently vague</font> and confusing and we     <font color="blue">cannot assure</font> that <font color="blue">government</font>al investigators, private insurers or private     <font color="blue">whistleblowers will</font> not challenge our practices</td>
    </tr>
    <tr>
      <td>28     ______________________________________________________________________    [49]Table of <font color="blue">Contents       </font>State <font color="blue">law limitations</font> and <font color="blue"><font color="blue">prohibition</font>s on</font> the <font color="blue">corporate practice</font> of medicine     may <font color="blue">materially</font> harm our business and <font color="blue">limit how</font> we can operate</td>
    </tr>
    <tr>
      <td>State <font color="blue">government</font>al <font color="blue">authorities</font> regulate the medical industry and medical     <font color="blue">practices extensively</font></td>
    </tr>
    <tr>
      <td>Many states have <font color="blue">corporate practice</font> of <font color="blue">medicine laws</font>     <font color="blue">which prohibit us from</font>:           •   <font color="blue">employing physicians</font>;           •   practicing medicine, which, in some states, includes managing or     operating a <font color="blue">radiation <font color="blue">treatment center</font></font>;           •   <font color="blue">certain types</font> of fee <font color="blue">arrangements</font> with physicians;           •   owning or <font color="blue">controlling</font> equipment used in a <font color="blue">medical practice</font>;           •   <font color="blue">setting fees charged</font> for <font color="blue">physician services</font>;           •   maintaining a physician’s patient records; or           •   <font color="blue">controlling</font> the content of <font color="blue">physician advertisements</font></td>
    </tr>
    <tr>
      <td>In addition, many states <font color="blue">impose limits on</font> the tasks a <font color="blue">physician may delegate</font>     to other <font color="blue">staff members</font></td>
    </tr>
    <tr>
      <td>We have <font color="blue">administrative</font> services <font color="blue"><font color="blue">agreement</font>s</font> in states     that  prohibit  the  corporate  practice  of <font color="blue">medicine such as</font> Alabama,     California, Maryland, Massachusetts, Nevada, New York and North Carolina</td>
    </tr>
    <tr>
      <td><font color="blue">Corporate </font>practice of <font color="blue">medicine laws</font> and their <font color="blue"><font color="blue">interpretation</font> vary from</font> state     to state, and <font color="blue">regulatory</font> <font color="blue">authorities</font> enforce them with broad discretion</td>
    </tr>
    <tr>
      <td>If     we are in violation of these laws, we could be required to <font color="blue">restructure</font> our     <font color="blue"><font color="blue">agreement</font>s</font>  which  could <font color="blue">materially</font> harm our business and <font color="blue">limit how</font> we     operate</td>
    </tr>
    <tr>
      <td>In the event the <font color="blue">corporate practice</font> of <font color="blue">medicine laws</font> of other     states would <font color="blue">adversely</font> limit our ability to operate, it <font color="blue">could prevent us</font>     <font color="blue">from expanding into</font> the particular state and impact our <font color="blue">growth strategy</font></td>
    </tr>
    <tr>
      <td>If  we  fail to <font color="blue">comply with</font> the laws and <font color="blue">regulations</font> applicable to our     <font color="blue">treatment center</font> <font color="blue">operations</font>, we <font color="blue">could suffer</font> penalties or be required to     make <font color="blue">significant</font> changes to our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">treatment center</font> <font color="blue">operations</font> are subject to many laws and <font color="blue">regulations</font> at     the federal, state and local <font color="blue">government</font> levels</td>
    </tr>
    <tr>
      <td>These laws and <font color="blue">regulations</font>     require that our <font color="blue"><font color="blue">treatment center</font>s</font> meet various licensing, certification and     other <font color="blue">requirements</font>, including those relating to:         •   <font color="blue">qualification</font> of medical and <font color="blue">support persons</font>;         •   pricing of <font color="blue">services by healthcare providers</font>;         •   the adequacy of medical care, equipment, personnel, operating policies     and procedures;         •   <font color="blue">clinic licensure</font> and <font color="blue">certificates</font> of need;         •   maintenance and protection of records; or         •   environmental protection, health and safety</td>
    </tr>
    <tr>
      <td>While we attempt to <font color="blue">comply with</font> all <font color="blue">applicable laws</font> and <font color="blue">regulations</font> some of     which can be complex and subject to <font color="blue">interpretation</font>, our <font color="blue"><font color="blue">treatment center</font>s</font>     may fail to <font color="blue">comply with</font> all <font color="blue">applicable laws</font> and <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>If we fail or     have failed to <font color="blue">comply with</font> <font color="blue">applicable laws</font> and <font color="blue">regulations</font>, we <font color="blue">could suffer</font>     civil or <font color="blue">criminal penalties</font>, including becoming the subject of cease and     desist orders, rejection of the payment of our claims, the loss of our     licenses to operate and our ability to <font color="blue">participate</font> in <font color="blue">government</font> or private     <font color="blue">healthcare programs</font></td>
    </tr>
    <tr>
      <td>29     ______________________________________________________________________    [50]Table of <font color="blue">Contents       </font>If we fail to <font color="blue">comply with</font> the federal anti-kickback statute, we could be     subject to criminal and civil penalties, loss of licenses and <font color="blue">exclusion from</font>     the <font color="blue">Medicare and Medicaid </font>programs, <font color="blue">which could</font> <font color="blue">materially</font> harm us</td>
    </tr>
    <tr>
      <td>A provision of the Social Security Act, <font color="blue">commonly referred</font> to as the federal     anti-kickback statute, prohibits the offer, payment, solicitation or receipt     of any form of <font color="blue">remuneration</font> in return for referring, ordering, leasing,     purchasing or arranging for or <font color="blue">recommending</font> the ordering, purchasing or     leasing of items or <font color="blue">services payable by</font> Medicare, Medicaid or any other     <font color="blue">federally funded healthcare program</font></td>
    </tr>
    <tr>
      <td>The federal anti-kickback statute is     very broad in scope and many of its provisions have not <font color="blue">been uniformly</font> or     <font color="blue">definitively interpreted by existing case law</font> or <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>All of our     financial <font color="blue"><font color="blue">relationship</font>s</font> with healthcare providers are <font color="blue">potentially</font> implicated     by this statute to the extent Medicare or Medicaid referrals are implicated</td>
    </tr>
    <tr>
      <td><font color="blue">Financial </font><font color="blue"><font color="blue">relationship</font>s</font> covered by this statute can include any <font color="blue">relationship</font>     where  <font color="blue">remuneration</font>  is  provided for referrals including payments not     commensurate with fair market value, whether in the form of space, equipment     leases,  <font color="blue">professional</font> or <font color="blue">technical services</font> or anything else of value</td>
    </tr>
    <tr>
      <td><font color="blue">Violations </font>of the federal anti-kickback statute may result in substantial     civil or <font color="blue">criminal penalties</font>, including <font color="blue">criminal fines</font> of up to dlra25cmam000,     <font color="blue">imprisonment</font> of up to five years, civil penalties under the Civil Monetary     Penalties Law of up to dlra50cmam000 for each violation, plus three times the     <font color="blue">remuneration</font> involved, civil penalties under the <font color="blue">False Claims Act </font>of up to     dlra11cmam000 for each claim submitted, plus three times the amounts paid for such     claims  and  <font color="blue">exclusion from</font> <font color="blue">participation</font> in the <font color="blue">Medicare and Medicaid </font>    programs</td>
    </tr>
    <tr>
      <td>The exclusion, if applied to us or one or more of our <font color="blue">subsidiaries</font>     or  affiliate personnel, could result in <font color="blue">significant</font> reductions in our     revenues  and could have a material adverse effect on our business</td>
    </tr>
    <tr>
      <td>In     addition, most of the states in which we operate, including Florida, have     also  <font color="blue">adopted laws</font>, similar to the federal anti-kickback statute, that     <font color="blue">prohibit payments</font> to physicians in exchange for referrals, some of which     <font color="blue">apply regardless</font> of the source of payment for care</td>
    </tr>
    <tr>
      <td>These <font color="blue">statutes typically</font>     <font color="blue">impose criminal</font> and <font color="blue">civil penalties as well as loss</font> of licenses</td>
    </tr>
    <tr>
      <td>If we fail to <font color="blue">comply with</font> the provision of the <font color="blue">Civil Monetary Penalties Law     </font>relating to <font color="blue"><font color="blue">inducements</font> provided</font> to patients, we could be subject to civil     penalties and <font color="blue">exclusion from</font> the <font color="blue">Medicare and Medicaid </font>programs, <font color="blue">which could</font>     <font color="blue">materially</font> harm us</td>
    </tr>
    <tr>
      <td>Under  a  provision of the federal Civil Monetary Penalties Law, civil     <font color="blue">monetary penalties</font> (and exclusion) may be <font color="blue">imposed on</font> any person who offers     or transfers <font color="blue">remuneration</font> to any patient who is a <font color="blue">Medicare or Medicaid     </font><font color="blue">beneficiary</font>, when the person knows or should know that the <font color="blue">remuneration</font> is     likely to induce the patient to receive <font color="blue">medical services from</font> a particular     provider</td>
    </tr>
    <tr>
      <td>This <font color="blue">broad provision applies</font> to many kinds of <font color="blue">inducements</font> or     <font color="blue">benefits provided</font> to patients, including complimentary items, services or     <font color="blue">transportation</font> that are of more than a <font color="blue">nominal value</font></td>
    </tr>
    <tr>
      <td>We have reviewed our     practices of <font color="blue">providing services</font> to our patients, and have structured those     services  in  a  manner  that we believe <font color="blue">complies with</font> the Law and its     <font color="blue">interpretation</font> by <font color="blue">government</font> <font color="blue">authorities</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot provide assurances</font>,     however, that <font color="blue">government</font> <font color="blue">authorities</font> will not take a contrary view and     impose  civil  monetary  penalties  and <font color="blue">exclude us</font> for past or present     practices</td>
    </tr>
    <tr>
      <td>Our  business  could  be <font color="blue">materially</font> <font color="blue">harmed by</font> future <font color="blue">interpretation</font> or     <font color="blue">implementation</font> of state laws regarding <font color="blue"><font color="blue">prohibition</font>s on</font> fee-splitting</td>
    </tr>
    <tr>
      <td>Many states, including Florida where 24 of our 68 <font color="blue"><font color="blue">treatment center</font>s</font> are     located, prohibit the splitting or sharing of <font color="blue">fees between physicians</font> and     non-physicians</td>
    </tr>
    <tr>
      <td>These <font color="blue">laws vary from</font> state to state and are <font color="blue">enforced by</font>     courts and <font color="blue">regulatory</font> agencies, each with broad discretion</td>
    </tr>
    <tr>
      <td>Some states have     interpreted  certain  types of fee <font color="blue">arrangements</font> in practice <font color="blue">management</font>     <font color="blue"><font color="blue">agreement</font>s</font> between entities and physicians as unlawful fee-splitting</td>
    </tr>
    <tr>
      <td>We     believe our <font color="blue">arrangements</font> with physicians comply in all material respects     with the fee-splitting laws of the states in which we operate</td>
    </tr>
    <tr>
      <td>Nevertheless,     it is possible <font color="blue">regulatory</font> <font color="blue">authorities</font> or other <font color="blue">parties could</font> claim we are     engaged in fee-splitting</td>
    </tr>
    <tr>
      <td>If such a claim were <font color="blue">successfully</font> asserted in any     <font color="blue">jurisdiction</font>, we and our <font color="blue">radiation <font color="blue">oncologists</font></font> could be subject to civil and     <font color="blue">criminal penalties</font> and we could be required to <font color="blue">restructure</font> our <font color="blue">contractual</font>     and other <font color="blue">arrangements</font></td>
    </tr>
    <tr>
      <td>Any <font color="blue">restructuring</font> of our <font color="blue">contractual</font> and other     <font color="blue">arrangements</font> with physician practices could result in <font color="blue">lower revenue from</font>     such practices and <font color="blue">reduced influence over</font> the business <font color="blue">decisions</font> of such     practices</td>
    </tr>
    <tr>
      <td>Alternatively, some of our <font color="blue">existing contracts could</font> be found to     be illegal and unenforceable, <font color="blue">which could</font> result in the <font color="blue">termination</font> of those     contracts and an <font color="blue">associated loss</font> of revenue</td>
    </tr>
    <tr>
      <td>In addition, expansion of our     <font color="blue">operations</font> to other states <font color="blue">with certain</font> types of fee-splitting <font color="blue">prohibition</font>s     may  require structural and <font color="blue">organizational modification</font> to the form of     <font color="blue"><font color="blue">relationship</font>s</font>  that  we  currently  have with physicians, <font color="blue">professional</font>     <font color="blue"><font color="blue">corporation</font>s</font> and hospitals</td>
    </tr>
    <tr>
      <td>If our <font color="blue">operations</font> <font color="blue">in New York</font> are found not to be in <font color="blue">compliance with</font> New     York law, we may be unable to continue or expand our <font color="blue">operations</font> <font color="blue">in New York</font></td>
    </tr>
    <tr>
      <td>We estimate that approximately 11prca, 9prca and 7prca of <font color="blue">total revenues</font> for 2003,     2004 and 2005, <font color="blue">respectively</font>, was <font color="blue">derived from</font> our New York <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>New     York  law  prohibits a business <font color="blue">corporation</font> such as us from practicing     medicine in the state</td>
    </tr>
    <tr>
      <td>As a result, we do not employ <font color="blue">radiation <font color="blue">oncologists</font></font>     or  any  other  physician  or licensed health care provider to provide     <font color="blue">professional</font> services <font color="blue">in New York</font></td>
    </tr>
    <tr>
      <td>We do provide certain <font color="blue">management</font> and     <font color="blue">administrative</font> services to <font color="blue">health care providers</font>, including physicians</td>
    </tr>
    <tr>
      <td>These services and the payments received for them are <font color="blue">regulated by</font> <font color="blue">New York     </font>law</td>
    </tr>
    <tr>
      <td>We believe we                                           30     ______________________________________________________________________    [51]Table of <font color="blue">Contents       </font>have structured our services <font color="blue">arrangements</font> with <font color="blue">health care providers</font> to     <font color="blue">comply with</font> these laws</td>
    </tr>
    <tr>
      <td>New York also prohibits for-profit <font color="blue"><font color="blue">corporation</font>s</font> from     owning a <font color="blue">licensed healthcare <font color="blue">facility</font></font></td>
    </tr>
    <tr>
      <td>We do not own any interests in any     licensed  New  York  <font color="blue">health care <font color="blue">facilities</font></font></td>
    </tr>
    <tr>
      <td>New York <font color="blue">additional</font>ly has     <font color="blue">regulations</font> concerning the <font color="blue">administration</font> of radiation and <font color="blue">rules governing</font>     financial and referral <font color="blue"><font color="blue">relationship</font>s</font> with physicians who <font color="blue">provide radiation</font>     <font color="blue">therapy services</font></td>
    </tr>
    <tr>
      <td>Although we believe our <font color="blue">operations</font> and <font color="blue"><font color="blue">relationship</font>s</font> in     New York are in material <font color="blue">compliance with</font> these laws, if New York <font color="blue">regulatory</font>     <font color="blue">authorities</font> or a <font color="blue">third party</font> asserts a <font color="blue">contrary position</font>, our <font color="blue">New York     </font><font color="blue">operations</font> could be harmed and we may be unable to continue or expand our     <font color="blue">operations</font> <font color="blue">in New York</font></td>
    </tr>
    <tr>
      <td>If a federal or state agency asserts a <font color="blue">different</font> position or enacts new laws     or <font color="blue">regulations</font> regarding illegal payments under the Medicare, Medicaid or     other  <font color="blue">government</font>al  programs, we may be subject to civil and criminal     penalties, experience a <font color="blue">significant</font> reduction in our revenue or be excluded     from <font color="blue">participation</font> in the Medicare, Medicaid or other <font color="blue">government</font>al programs</td>
    </tr>
    <tr>
      <td>Any change in <font color="blue">interpretation</font>s or <font color="blue">enforcement</font> of existing or new laws and     <font color="blue">regulations</font> could subject our current business practices to <font color="blue">allegations</font> of     <font color="blue">impropriety</font>  or <font color="blue">illegality</font>, or could require us to make changes in our     treatment  centers, equipment, personnel, services, pricing or capital     expenditure programs, <font color="blue">which could</font> increase our operating expenses and have a     material  adverse effect on our <font color="blue">operations</font> or reduce the demand for or     <font color="blue">profitability</font> of our services</td>
    </tr>
    <tr>
      <td>Additionally, new federal or state laws may be enacted that would cause our     <font color="blue"><font color="blue">relationship</font>s</font> with our <font color="blue">radiation <font color="blue">oncologists</font></font> to <font color="blue">become illegal</font> or result in     the imposition of penalties <font color="blue">against us</font> or our <font color="blue"><font color="blue">treatment center</font>s</font></td>
    </tr>
    <tr>
      <td>If any of     our business <font color="blue">arrangements</font> with our <font color="blue">radiation <font color="blue">oncologists</font></font> or other physicians     in a position to make referrals of radiation <font color="blue">therapy services</font> were deemed to     violate the federal anti-kickback statute or similar laws, or if new federal     or  state  laws were enacted rendering these <font color="blue">arrangements</font> illegal, our     business would be <font color="blue"><font color="blue">adversely</font> affected</font></td>
    </tr>
    <tr>
      <td>If we fail to <font color="blue">comply with</font> physician self-referral laws as they are currently     interpreted or may be interpreted in the future, or if other <font color="blue">legislative</font>     <font color="blue">restrictions</font> are issued, we <font color="blue">could incur</font> a <font color="blue">significant</font> loss of <font color="blue">reimbursement</font>     revenue</td>
    </tr>
    <tr>
      <td>We  are  subject to federal and state statutes and <font color="blue">regulations</font> banning     payments for referrals of patients and referrals <font color="blue">by physicians</font> to healthcare     <font color="blue">providers with whom</font> the physicians have a financial <font color="blue">relationship</font> and billing     for <font color="blue">services provided pursuant</font> to <font color="blue">such referrals</font> if any occur</td>
    </tr>
    <tr>
      <td>The federal     <font color="blue">Stark Law </font>applies to <font color="blue">Medicare and Medicaid </font>and prohibits a physician from     referring  patients for certain services, including radiation therapy,     <font color="blue">radiology</font> and <font color="blue">laboratory</font> services, to an entity with which the physician has     a financial <font color="blue">relationship</font></td>
    </tr>
    <tr>
      <td><font color="blue">Financial </font><font color="blue">relationship</font> includes <font color="blue">both investment</font>     interests in an entity and compensation <font color="blue">arrangements</font> with an entity</td>
    </tr>
    <tr>
      <td>The     state laws and <font color="blue">regulations</font> vary <font color="blue">significant</font>ly from state to state, are often     vague and, in many cases, have not <font color="blue">been interpreted by courts</font> or <font color="blue">regulatory</font>     agencies</td>
    </tr>
    <tr>
      <td>These state laws and <font color="blue">regulations</font> <font color="blue">generally</font> apply to services     reimbursed by both <font color="blue">government</font>al and <font color="blue">private payors</font></td>
    </tr>
    <tr>
      <td><font color="blue">Violation </font>of these     federal and state laws and <font color="blue">regulations</font> may result in <font color="blue">prohibition</font> of payment     for services rendered, loss of licenses, fines, <font color="blue">criminal penalties</font> and     <font color="blue">exclusion from</font> <font color="blue">Medicare and Medicaid </font>programs</td>
    </tr>
    <tr>
      <td>We have financial <font color="blue"><font color="blue">relationship</font>s</font> with our physicians, as defined by the     federal Stark Law, in the form of compensation <font color="blue">arrangements</font> and ownership of     our <font color="blue">common stock</font> issued by us in <font color="blue">connection</font> with <font color="blue">acquisition</font>s</td>
    </tr>
    <tr>
      <td>We also have     financial <font color="blue">arrangements</font> with physicians who refer <font color="blue">Medicare and Medicaid </font>    patients to us, which <font color="blue"><font color="blue">relationship</font>s</font> are also subject to the Stark Law</td>
    </tr>
    <tr>
      <td>We     <font color="blue">rely on certain exceptions</font> to self-referral laws including an exception for     <font color="blue">radiation <font color="blue">oncologists</font></font> referrals of radiation <font color="blue">therapy services</font>, as well as     employee, group practice and in-office ancillary services exceptions, that     we  believe are applicable to our <font color="blue">arrangements</font></td>
    </tr>
    <tr>
      <td>In a limited number of     markets we have <font color="blue"><font color="blue">relationship</font>s</font> with non-radiation oncology physicians such as     surgical and <font color="blue">gynecological</font> <font color="blue">oncologists</font> and urologists that are members of a     group <font color="blue">practice with</font> our <font color="blue">radiation <font color="blue">oncologists</font></font> and we rely on the group     <font color="blue">practice exception</font> to self-referral laws with respect to such <font color="blue"><font color="blue">relationship</font>s</font></td>
    </tr>
    <tr>
      <td>While  we believe that our financial <font color="blue"><font color="blue">relationship</font>s</font> with physicians and     <font color="blue">referral practices</font> are in material <font color="blue">compliance with</font> <font color="blue">applicable laws</font> and     <font color="blue">regulations</font>,  <font color="blue">government</font> <font color="blue">authorities</font> might take a <font color="blue">contrary position</font> or     <font color="blue"><font color="blue">prohibited referrals</font> may</font> occur</td>
    </tr>
    <tr>
      <td>We cannot be certain that physicians who own     our <font color="blue">common stock</font> or hold <font color="blue">promissory</font> notes will not violate these laws or     that we will have knowledge of the identity of all <font color="blue">beneficial owners</font> of our     <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>If our financial <font color="blue"><font color="blue">relationship</font>s</font> with physicians were found to     be illegal, or if <font color="blue">prohibited referrals</font> were found to have been made, we     could be subject to civil and <font color="blue">criminal penalties</font>, including fines, exclusion     from <font color="blue">participation</font> in <font color="blue">government</font> and <font color="blue">private payor programs</font> and <font color="blue">requirements</font>     to <font color="blue">refund amounts previously</font> received from <font color="blue">government</font> and <font color="blue">private payors</font></td>
    </tr>
    <tr>
      <td>In     addition,  expansion  of  our  <font color="blue">operations</font> to new <font color="blue">jurisdiction</font>s, or new     <font color="blue">interpretation</font>s  of  laws in our existing <font color="blue">jurisdiction</font>s, could require     structural  and <font color="blue">organizational modification</font>s of our <font color="blue"><font color="blue">relationship</font>s</font> with     physicians to <font color="blue">comply with</font> that <font color="blue">jurisdiction</font>’s laws</td>
    </tr>
    <tr>
      <td>Such structural and     <font color="blue">organizational modification</font>s could result in lower <font color="blue">profitability</font> and failure     to achieve our <font color="blue">growth objectives</font></td>
    </tr>
    <tr>
      <td>31     ______________________________________________________________________    [52]Table of <font color="blue">Contents       </font>Our costs and <font color="blue">potential risks</font> have <font color="blue">increased as</font> a result of the <font color="blue">regulations</font>     relating to privacy and security of patient information</td>
    </tr>
    <tr>
      <td>There  are  numerous  federal and state <font color="blue">regulations</font> addressing patient     information  privacy and <font color="blue">security concerns</font></td>
    </tr>
    <tr>
      <td>In particular, the federal     <font color="blue">regulations</font> issued under the Health Insurance Portability and Accountability     Act of 1996, or HIPAA, <font color="blue">contain provisions</font> that:           •   protect individual <font color="blue">privacy by limiting</font> the uses and <font color="blue">disclosures</font> of     patient information;           •   require the <font color="blue">implementation</font> of <font color="blue">security safeguards</font> to ensure the     confidentiality, integrity and <font color="blue">availability</font> of <font color="blue">individually identifiable</font>     health information in <font color="blue">electronic</font> form; and           •   <font color="blue">prescribe specific <font color="blue">transaction</font> formats</font> and <font color="blue">data code sets</font> for certain     <font color="blue">electronic</font> healthcare <font color="blue">transaction</font>s</td>
    </tr>
    <tr>
      <td><font color="blue">Compliance  </font>with  these <font color="blue">regulations</font> requires us to spend money and our     <font color="blue">management</font> to spend substantial time and resources</td>
    </tr>
    <tr>
      <td>We believe that we are     in  material  compliance  with the HIPAA <font color="blue">regulations</font> with which we are     currently required to comply</td>
    </tr>
    <tr>
      <td><font color="blue">The HIPAA </font><font color="blue">regulations</font> expose us to increased     <font color="blue">regulatory</font> risk if we fail to comply</td>
    </tr>
    <tr>
      <td>If we fail to <font color="blue">comply with</font> the new     <font color="blue">regulations</font>, we <font color="blue">could suffer</font> civil penalties up to dlra100 per violation with a     <font color="blue">maximum penalty</font> of dlra25cmam000 per each requirement violated per calendar year     and <font color="blue">criminal penalties</font> with fines up to dlra250cmam000 per violation, and our     business could be harmed</td>
    </tr>
    <tr>
      <td>Efforts to regulate the <font color="blue">construction</font>, <font color="blue">acquisition</font> or expansion of healthcare     <font color="blue"><font color="blue">treatment center</font>s</font> <font color="blue">could prevent us</font> from developing or acquiring <font color="blue">additional</font>     <font color="blue"><font color="blue">treatment center</font>s</font> or other <font color="blue">facilities</font> or renovating our <font color="blue">existing treatment</font>     centers</td>
    </tr>
    <tr>
      <td>Many  states have <font color="blue">enacted certificate</font> of need laws which require prior     approval  for the <font color="blue">construction</font>, <font color="blue">acquisition</font> or expansion of healthcare     <font color="blue"><font color="blue">treatment center</font>s</font></td>
    </tr>
    <tr>
      <td>In <font color="blue">giving approval</font>, these states consider the need for     <font color="blue">additional</font> or expanded healthcare <font color="blue"><font color="blue">treatment center</font>s</font> or services</td>
    </tr>
    <tr>
      <td>In the     states of Kentucky, North Carolina and Rhode Island in which we currently     operate, <font color="blue">certificates</font> of need must be obtained for capital <font color="blue">expenditures</font>     exceeding a prescribed amount, changes in <font color="blue">capacity</font> or services offered and     various other matters</td>
    </tr>
    <tr>
      <td>Other states in which we now or may in the future     operate may also require <font color="blue">certificates</font> of need under certain <font color="blue">circumstances</font>     not <font color="blue">currently applicable</font> to us</td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot assure</font> you that we will be able to     obtain the <font color="blue">certificates</font> of need or other required approvals for <font color="blue">additional</font>     or expanded <font color="blue"><font color="blue">treatment center</font>s</font> or services in the future</td>
    </tr>
    <tr>
      <td>In addition, at the     time we acquire a <font color="blue">treatment center</font>, we may agree to replace or expand the     acquired <font color="blue">treatment center</font></td>
    </tr>
    <tr>
      <td>If we are unable to obtain required approvals, we     may not be able to acquire <font color="blue">additional</font> <font color="blue"><font color="blue">treatment center</font>s</font> or other <font color="blue">facilities</font>,     expand the <font color="blue">healthcare services</font> we <font color="blue">provide at</font> these <font color="blue"><font color="blue">treatment center</font>s</font> or     replace or expand acquired <font color="blue"><font color="blue">treatment center</font>s</font></td>
    </tr>
    <tr>
      <td>Our business may be <font color="blue">harmed by</font> <font color="blue">technological</font> and <font color="blue">therapeutic</font> changes</td>
    </tr>
    <tr>
      <td>The treatment of <font color="blue">cancer patients</font> is subject to <font color="blue">potentially</font> revolutionary     <font color="blue">technological</font> and <font color="blue">therapeutic</font> changes</td>
    </tr>
    <tr>
      <td>Future <font color="blue">technological</font> <font color="blue">development</font>s     could render our <font color="blue">equipment obsolete</font></td>
    </tr>
    <tr>
      <td>We may incur <font color="blue">significant</font> costs in     replacing or <font color="blue">modifying equipment</font> in which we have already made a substantial     <font color="blue">investment prior</font> to the end of its anticipated useful life</td>
    </tr>
    <tr>
      <td>In addition,     there may be <font color="blue">significant</font> advances in other cancer treatment methods, such as     <font color="blue">chemotherapy</font>,  surgery,  biological  therapy,  or in <font color="blue">cancer prevention</font>     techniques, <font color="blue">which could</font> reduce demand or <font color="blue">even eliminate</font> the need for the     radiation <font color="blue">therapy services</font> we provide</td>
    </tr>
    <tr>
      <td>We maintain a <font color="blue"><font color="blue">significant</font> amount</font> of debt to further our business or growth     strategies</td>
    </tr>
    <tr>
      <td>As  of  <font color="blue">December </font>31,  2005, we had <font color="blue">outstanding debt</font> of dlra123dtta5 million</td>
    </tr>
    <tr>
      <td><font color="blue">Approximately </font>dlra189dtta7 million is available for borrowing in the <font color="blue">future under</font>     our  fourth  amended  and <font color="blue">restated <font color="blue">senior secured</font></font> credit <font color="blue">facility</font></td>
    </tr>
    <tr>
      <td>Our     <font color="blue">significant</font> indebtedness could have <font color="blue">adverse consequences</font> and <font color="blue">could limit</font> our     business as follows:           •   a substantial portion our cash flows from <font color="blue">operations</font> may go to     repayment of principal and <font color="blue">interest on</font> our indebtedness and we would have     <font color="blue">less funds available</font> for our <font color="blue">operations</font>;           •   our senior credit <font color="blue">facility</font> contains numerous financial and other     <font color="blue">restrictive covenants</font>, including <font color="blue">restrictions</font> on purchasing assets, selling     assets, <font color="blue">paying dividends</font> to our <font color="blue"><font color="blue">shareholder</font>s</font> and incurring <font color="blue">additional</font>     indebtedness;           •   as a result of our debt we may be vulnerable to <font color="blue">adverse general</font>     economic and industry <font color="blue">conditions</font> and we may have <font color="blue">less flexibility</font> in     reacting to changes in these <font color="blue">conditions</font>; or           •   <font color="blue"><font color="blue">competitors</font> <font color="blue">with greater</font> access</font> to <font color="blue">capital could</font> have a <font color="blue">significant</font>     <font color="blue">advantage over us</font></td>
    </tr>
    <tr>
      <td>32     ______________________________________________________________________    [53]Table of <font color="blue">Contents       </font>We may need to raise <font color="blue">additional</font> capital, which may be <font color="blue">difficult</font> to obtain at     <font color="blue">attractive prices</font> and which may cause us to engage in <font color="blue">financing <font color="blue">transaction</font>s</font>     that <font color="blue">adversely</font> affect our stock price</td>
    </tr>
    <tr>
      <td>We may need capital for growth, <font color="blue">acquisition</font>s, <font color="blue">development</font>, integration of     <font color="blue">operations</font>  and <font color="blue">technology</font> and equipment in the future</td>
    </tr>
    <tr>
      <td>Any <font color="blue">additional</font>     capital  would be <font color="blue">raised through public</font> or <font color="blue">private offerings</font> of equity     securities or <font color="blue">debt financings</font></td>
    </tr>
    <tr>
      <td>Our issuance of <font color="blue">additional</font> equity securities     could cause dilution to holders of our <font color="blue">common stock</font> and may <font color="blue">adversely</font> affect     the <font color="blue">market price</font> of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>The incurrence of <font color="blue">additional</font> debt     could increase our <font color="blue">interest expense</font> and other <font color="blue">debt service <font color="blue">obligations</font></font> and     could result in the imposition of covenants that restrict our operational     and <font color="blue">financial flexibility</font></td>
    </tr>
    <tr>
      <td><font color="blue">Additional </font><font color="blue">capital may</font> not be available to us on     <font color="blue">commercially reasonable terms</font> or at all</td>
    </tr>
    <tr>
      <td>The failure to raise <font color="blue">additional</font>     needed <font color="blue">capital could</font> impede the <font color="blue">implementation</font> of our operating and growth     strategies</td>
    </tr>
    <tr>
      <td>Our information systems are critical to our business and a failure of those     systems could <font color="blue">materially</font> harm us</td>
    </tr>
    <tr>
      <td>We  depend  on  our  ability  to store, retrieve, process and manage a     <font color="blue"><font color="blue">significant</font> amount</font> of information, and to provide our <font color="blue">radiation treatment</font>     <font color="blue">centers with efficient</font> and <font color="blue">effective accounting</font> and <font color="blue">scheduling systems</font></td>
    </tr>
    <tr>
      <td>If     our information <font color="blue">systems fail</font> to perform as expected, or if we suffer an     interruption, malfunction or loss of information <font color="blue">processing capabilities</font>, it     could have a material adverse effect on our business</td>
    </tr>
    <tr>
      <td>Our financial results could be <font color="blue"><font color="blue">adversely</font> affected</font> by the <font color="blue">increasing costs</font> of     <font color="blue">professional</font> <font color="blue">liability</font> insurance and <font color="blue">by successful malpractice</font> claims</td>
    </tr>
    <tr>
      <td>We  are exposed to the risk of <font color="blue">professional</font> <font color="blue">liability</font> and other claims     against  us  and  our  radiation  <font color="blue">oncologists</font> and other physicians and     <font color="blue">professional</font>s arising out of <font color="blue">patient medical treatment at</font> our treatment     centers</td>
    </tr>
    <tr>
      <td>Our <font color="blue">risk exposure as</font> it relates to our non-radiation oncology     <font color="blue">physicians could</font> be <font color="blue">greater than with</font> our <font color="blue">radiation <font color="blue">oncologists</font></font> to the     extent such non-radiation oncology physicians are engaged in <font color="blue">diagnostic</font>     <font color="blue">activities</font></td>
    </tr>
    <tr>
      <td><font color="blue">Malpractice </font>claims, if successful, could result in substantial     <font color="blue">damage awards</font> which might exceed the limits of any <font color="blue">applicable insurance</font>     coverage</td>
    </tr>
    <tr>
      <td><font color="blue">Insurance  </font><font color="blue">against losses</font> of this type can be expensive and     insurance  premiums are expected to increase <font color="blue">significant</font>ly in the near     future</td>
    </tr>
    <tr>
      <td>Insurance <font color="blue">rates vary from</font> state to state, <font color="blue">by physician specialty</font> and     other factors</td>
    </tr>
    <tr>
      <td>The <font color="blue">rising costs</font> of insurance premiums, as well as successful     malpractice  claims  <font color="blue">against us</font> or one of our physicians, could have a     material adverse effect on our <font color="blue">financial position</font> and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>It is <font color="blue">also possible</font> that our excess <font color="blue">liability</font> and other <font color="blue">insurance coverage</font>     will not continue to be <font color="blue">available at</font> acceptable costs or on favorable terms</td>
    </tr>
    <tr>
      <td>In addition, our insurance does not cover all potential <font color="blue">liabilities</font> arising     from  <font color="blue">government</font>al fines and penalties, indemnification <font color="blue"><font color="blue">agreement</font>s</font> and     certain other <font color="blue">uninsurable losses</font></td>
    </tr>
    <tr>
      <td>For example, from time to time we agree to     indemnify third parties, such as hospitals and <font color="blue">clinical laboratories</font>, for     various claims that may not be <font color="blue">covered by insurance</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">radiation therapy market</font> is <font color="blue">highly competitive</font></td>
    </tr>
    <tr>
      <td><font color="blue">Radiation </font>therapy is a <font color="blue">highly competitive</font> business in <font color="blue">each market</font> in which     we operate</td>
    </tr>
    <tr>
      <td>Our <font color="blue"><font color="blue">treatment center</font>s</font> <font color="blue">face <font color="blue">competition</font></font> from hospitals, other     <font color="blue">medical practitioners</font> and other operators of radiation <font color="blue"><font color="blue">treatment center</font>s</font></td>
    </tr>
    <tr>
      <td>There is a <font color="blue">growing trend</font> of physicians in <font color="blue">specialties</font> other <font color="blue">than radiation</font>     oncology,  such  as urology, entering the <font color="blue">radiation treatment</font> business     including medical <font color="blue">specialties</font> that <font color="blue">would otherwise</font> be sources of referrals</td>
    </tr>
    <tr>
      <td>If  this <font color="blue">trend continues</font> it <font color="blue">could harm</font> our referrals and our business</td>
    </tr>
    <tr>
      <td>Certain of our <font color="blue">competitors</font> have longer operating histories and <font color="blue">significant</font>ly     greater financial and other <font color="blue">resources than us</font></td>
    </tr>
    <tr>
      <td><font color="blue">Competitors </font><font color="blue">with greater</font>     access to <font color="blue">financial resources may enter</font> our markets and <font color="blue">compete with us</font></td>
    </tr>
    <tr>
      <td>In     the event that we are not able to compete <font color="blue">successfully</font>, our business may be     <font color="blue"><font color="blue">adversely</font> affected</font> and <font color="blue">competition</font> may make it more <font color="blue">difficult</font> for us to     <font color="blue">affiliate with</font> <font color="blue">additional</font> <font color="blue">radiation <font color="blue">oncologists</font></font> on terms that are favorable     to us</td>
    </tr>
    <tr>
      <td>Our financial results may suffer if we have to write-off goodwill or other     <font color="blue">intangible assets</font></td>
    </tr>
    <tr>
      <td>A portion of our <font color="blue">total assets consist</font> of goodwill and other intangible     assets</td>
    </tr>
    <tr>
      <td><font color="blue">Goodwill  </font>and  other  intangible  assets,  net of <font color="blue">accumulated</font>     <font color="blue">amortization</font>, accounted for 22prca and 28prca of the <font color="blue">total assets on</font> our balance     sheet as of <font color="blue">December </font>31, 2004 and 2005, <font color="blue">respectively</font></td>
    </tr>
    <tr>
      <td>We may not realize the     value of our goodwill or other <font color="blue">intangible assets</font></td>
    </tr>
    <tr>
      <td>We expect to engage in     <font color="blue">additional</font> <font color="blue">transaction</font>s that will result in our <font color="blue">recognition</font> of <font color="blue">additional</font>     goodwill or other <font color="blue">intangible assets</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">evaluate on</font> a <font color="blue">regular basis whether</font>     events and <font color="blue">circumstances</font> have occurred that indicate that all or a portion     of the carrying amount of goodwill or other <font color="blue">intangible assets</font> may no longer     be recoverable, and is <font color="blue">therefore impaired</font></td>
    </tr>
    <tr>
      <td>Under <font color="blue">current accounting rules</font>,     any de<font color="blue">termination</font> that <font color="blue">impairment</font> has occurred would require us to write-off     the impaired portion of our goodwill or the <font color="blue">unamortized</font> portion of our     <font color="blue">intangible assets</font>, resulting in a charge to our earnings</td>
    </tr>
    <tr>
      <td>Such a write-off     could have a material adverse effect on our financial condition and results     of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>33     ______________________________________________________________________    [54]Table of <font color="blue">Contents       </font>Our  failure  to <font color="blue">comply with</font> laws related to <font color="blue"><font color="blue">hazardous</font> materials could</font>     <font color="blue">materially</font> harm us</td>
    </tr>
    <tr>
      <td>Our <font color="blue"><font color="blue">treatment center</font>s</font> provide specialized treatment involving the use of     <font color="blue">radioactive</font> material in the treatment of the lungs, prostate, breasts,     cervix  and other organs</td>
    </tr>
    <tr>
      <td>The materials are obtained from, and, if not     <font color="blue">permanently placed</font> in a patient or used up, returned to, a third-party     provider of supplies to hospitals and other <font color="blue">radiation therapy practices</font>,     which has the <font color="blue">ultimate responsibility</font> for its proper disposal</td>
    </tr>
    <tr>
      <td>We, however,     remain  subject to state and <font color="blue">federal laws regulating</font> the protection of     employees who may be exposed to <font color="blue">hazardous</font> material and regulating the proper     handling, storage and disposal of that material</td>
    </tr>
    <tr>
      <td>Although we believe we are     in <font color="blue">compliance with</font> all <font color="blue">applicable laws</font>, a violation of such laws, or the     <font color="blue">future enactment</font> of more <font color="blue">stringent laws</font> or <font color="blue">regulations</font>, could subject us to     <font color="blue">liability</font>, or require us to <font color="blue">incur costs</font> that would have a material adverse     effect on us</td>
    </tr>
    <tr>
      <td>Because our principal <font color="blue"><font color="blue">shareholder</font>s</font> and <font color="blue">management</font> own a large percentage of     our <font color="blue">common stock</font>, they <font color="blue">will collectively</font> be able to determine the outcome of     all  matters  submitted to <font color="blue"><font color="blue">shareholder</font>s</font> for <font color="blue">approval regardless</font> of the     <font color="blue">preferences</font> of our other <font color="blue"><font color="blue">shareholder</font>s</font></td>
    </tr>
    <tr>
      <td>As  of  <font color="blue">February </font>1,  2006  certain  of our <font color="blue">officers beneficially</font> owned     approximately 46dtta5prca of our outstanding <font color="blue">common stock</font> and serve on our board     of <font color="blue">directors</font></td>
    </tr>
    <tr>
      <td>As a result, these persons have a <font color="blue">significant</font> influence over     the outcome of matters requiring <font color="blue">shareholder</font> approval including the power     to:           •   elect our entire board of <font color="blue">directors</font>;           •   control our <font color="blue">management</font> and policies;           •   agree to mergers, <font color="blue">consolidations</font> and the sale of all or <font color="blue">substantially</font>     all of our assets;           •   prevent or cause a change in control; and           •   amend our amended and <font color="blue">restated articles</font> of in<font color="blue">corporation</font> and bylaws at     any time</td>
    </tr>
    <tr>
      <td>Our <font color="blue">stock price may fluctuate</font> and you may not be able to resell your shares     of our <font color="blue">common stock</font> at or above the price you paid</td>
    </tr>
    <tr>
      <td>We became a <font color="blue">public company on</font> June 18, 2004 and there can be no assurance     that we will be able to maintain an <font color="blue">active market</font> for our stock</td>
    </tr>
    <tr>
      <td>A number of     <font color="blue">factors could</font> cause the <font color="blue">market price</font> of our <font color="blue">common stock</font> be volatile</td>
    </tr>
    <tr>
      <td><font color="blue">Some     </font>of the factors that could cause our stock price to fluctuate <font color="blue">significant</font>ly,     include:           •   <font color="blue">variations</font> in our financial performance;           •   changes in <font color="blue">recommendations</font> or financial estimates <font color="blue">by securities</font>     analysts, or our failure to meet or exceed estimates;           •   <font color="blue">announcements</font> by us or our <font color="blue">competitors</font> of material events;           •   <font color="blue">future sales</font> of our <font color="blue">common stock</font>;           •   <font color="blue">investor <font color="blue">perception</font>s</font> of us and the <font color="blue">healthcare industry</font>;           •   <font color="blue">announcements</font> regarding purported class <font color="blue">action lawsuits by plaintiff</font>     lawfirms; and           •   <font color="blue">general economic trends</font> and market <font color="blue">conditions</font></td>
    </tr>
    <tr>
      <td>Sales of substantial amounts of our <font color="blue">common stock</font>, by our <font color="blue">senior <font color="blue">management</font></font>     <font color="blue"><font color="blue">shareholder</font>s</font> could <font color="blue">adversely</font> affect our stock price and limit our ability to     <font color="blue">raise capital</font></td>
    </tr>
    <tr>
      <td>As of <font color="blue">February </font>1, 2006, our <font color="blue">senior <font color="blue">management</font></font> <font color="blue"><font color="blue">shareholder</font>s</font> beneficially     owned approximately 47dtta0prca of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">market price</font> of our     <font color="blue">common stock</font> could decline as a result of sales by <font color="blue">senior <font color="blue">management</font></font> of     substantial  amounts  of  our <font color="blue">common stock</font> in the <font color="blue">public market</font> or the     <font color="blue">perception</font> that substantial <font color="blue">sales could</font> occur</td>
    </tr>
    <tr>
      <td>These <font color="blue">sales also may</font> make it     more <font color="blue">difficult</font> for us to sell <font color="blue">common stock</font> in the future to <font color="blue">raise capital</font></td>
    </tr>
    <tr>
      <td>34     ______________________________________________________________________    [55]Table of <font color="blue">Contents       </font>Florida law and certain anti-takeover provisions of our <font color="blue">corporate documents</font>     and our executive <font color="blue">employment</font> <font color="blue"><font color="blue">agreement</font>s</font> could entrench our <font color="blue">management</font> or     delay or prevent a <font color="blue">third party</font> from acquiring us or a change in <font color="blue">control even</font>     if it <font color="blue">would benefit</font> our <font color="blue"><font color="blue">shareholder</font>s</font></td>
    </tr>
    <tr>
      <td>Our  amended and <font color="blue">restated articles</font> of in<font color="blue">corporation</font> and bylaws and our     executive <font color="blue">employment</font> <font color="blue"><font color="blue">agreement</font>s</font> contain a number of provisions that may     delay, deter or inhibit a future <font color="blue">acquisition</font> or change in control that is     not first <font color="blue">approved by</font> our board of <font color="blue">directors</font></td>
    </tr>
    <tr>
      <td>This could occur even if our     <font color="blue"><font color="blue">shareholder</font>s</font>  receive  an  attractive  offer  for their shares or if a     substantial  number or even a majority of our <font color="blue"><font color="blue">shareholder</font>s</font> believe the     <font color="blue">takeover may</font> be in their <font color="blue">best interest</font></td>
    </tr>
    <tr>
      <td>These provisions are intended to     encourage any person interested in acquiring us to <font color="blue">negotiate with</font> and obtain     approval  from our board of <font color="blue">directors</font> prior to pursuing a <font color="blue">transaction</font></td>
    </tr>
    <tr>
      <td><font color="blue">Provisions </font>that could delay, deter or inhibit a future <font color="blue">acquisition</font> or change     in control include the following:           •   10cmam000cmam000 shares of <font color="blue">blank check preferred stock</font> that may be issued by     our board of <font color="blue">directors</font> without <font color="blue">shareholder</font> approval and that may be     <font color="blue">substantially</font> dilutive or contain <font color="blue">preferences</font> or <font color="blue">rights objectionable</font> to an     acquiror;           •   a <font color="blue">classified board</font> of <font color="blue">directors</font> with staggered, three-year terms so     that only a portion of our <font color="blue">directors</font> are subject to <font color="blue">election at each annual</font>     meeting;           •   the ability of our board of <font color="blue">directors</font> to amend our <font color="blue">bylaws without</font>     <font color="blue">shareholder</font> approval;           •   <font color="blue">special meetings</font> of <font color="blue"><font color="blue">shareholder</font>s</font> cannot be <font color="blue">called by</font> a <font color="blue">shareholder</font>;           •   <font color="blue">obligations</font> to make certain payments under executive <font color="blue">employment</font>     <font color="blue"><font color="blue">agreement</font>s</font> in the event of a change in control; and           •   Florida <font color="blue">statutes which restrict</font> or prohibit “control share     <font color="blue">acquisition</font>s” and certain <font color="blue">transaction</font>s with affiliated parties and permit     the adoption of “poison pills” without <font color="blue">shareholder</font> approval</td>
    </tr>
    <tr>
      <td>These  <font color="blue">provisions could also discourage bids</font> for our <font color="blue">common stock</font> at a     premium  and cause the <font color="blue">market price</font> of our <font color="blue">common stock</font> to decline</td>
    </tr>
    <tr>
      <td>In     addition, these <font color="blue">provisions may also entrench</font> our <font color="blue">management</font> by preventing or     frustrating any <font color="blue">attempt by</font> our <font color="blue"><font color="blue">shareholder</font>s</font> to replace or remove our current     <font color="blue">management</font></td>
    </tr>
    <tr>
      <td>Other than <font color="blue">S Corporation </font><font color="blue">distributions</font> and our <font color="blue">special distribution</font>, we have     not <font color="blue">paid dividends</font> and do not expect to in the future, which means that the     value of our <font color="blue">shares cannot</font> be realized <font color="blue">except through sale</font></td>
    </tr>
    <tr>
      <td>Other than <font color="blue">S Corporation </font><font color="blue">distributions</font> to our <font color="blue"><font color="blue">shareholder</font>s</font>, including our     <font color="blue">special distribution</font> in April 2004 prior to our <font color="blue">initial public offering</font>, we     have never declared or <font color="blue">paid cash dividends</font></td>
    </tr>
    <tr>
      <td>We currently expect to retain     earnings for our business and do not anticipate <font color="blue"><font color="blue">paying dividends</font> on</font> our     common  stock at any time in the <font color="blue">foreseeable future</font></td>
    </tr>
    <tr>
      <td>Because we do not     anticipate  <font color="blue">paying dividends</font> in the future, it is likely that the only     <font color="blue">opportunity</font> to realize the value of our <font color="blue">common stock</font> will be through a sale     of those shares</td>
    </tr>
    <tr>
      <td>The <font color="blue">decision whether</font> to pay dividends on <font color="blue">common stock</font> will     be made by the board of <font color="blue">directors</font> from time to time in the exercise of its     business judgment</td>
    </tr>
    <tr>
      <td>Furthermore, we are <font color="blue">currently restricted from paying</font>     <font color="blue">dividends by</font> the terms of our <font color="blue">senior secured</font> credit <font color="blue">facility</font></td>
    </tr>
    <tr>
      <td>If we fail to maintain an <font color="blue">effective system</font> of <font color="blue">internal controls</font>, we may not     be able to <font color="blue">accurately</font> report our financial results <font color="blue">which could</font> subject us to     <font color="blue">regulatory</font> sanctions, harm our business and operating results and cause the     <font color="blue">trading price</font> of our stock to decline</td>
    </tr>
    <tr>
      <td>We are required under Section 404 of the Sarbanes-Oxley Act of 2002 to     evaluate  our  <font color="blue">internal controls</font> for <font color="blue">effectiveness</font></td>
    </tr>
    <tr>
      <td><font color="blue">Effective </font>internal     controls are <font color="blue">necessary</font> for us to <font color="blue">provide reliable financial</font> reports</td>
    </tr>
    <tr>
      <td>If we     cannot <font color="blue">provide reliable financial</font> reports, our business, reputation and     operating results could be harmed</td>
    </tr>
    <tr>
      <td>We have in the <font color="blue">past discovered</font>, and may     in  the  future  discover,  areas  of  our <font color="blue">internal controls</font> that need     <font color="blue">improvement</font></td>
    </tr>
    <tr>
      <td>For  example, in early May 2005 we identified a material     weakness related to our controls over <font color="blue">lease accounting</font>, which caused us to     restate our <font color="blue">prior financial statements</font></td>
    </tr>
    <tr>
      <td>While we have <font color="blue">since remediated</font> the     material  weakness to ensure proper <font color="blue">lease accounting</font> in the future and     believe that we currently have adequate <font color="blue">internal controls</font>, there can be no     assurance that we will be able to implement and maintain <font color="blue">adequate controls</font>     in the future</td>
    </tr>
    <tr>
      <td>We cannot be certain that these <font color="blue">measures will ensure</font> that we     implement and maintain <font color="blue">adequate controls</font> over our <font color="blue">financial processes</font> and     reporting in the future</td>
    </tr>
    <tr>
      <td>Any failure to implement required new or improved     controls, or <font color="blue">difficult</font>ies encountered in their <font color="blue">implementation</font>, could subject     us to <font color="blue">regulatory</font> sanctions, harm our business and operating results or cause     us to fail to meet our reporting <font color="blue">obligations</font></td>
    </tr>
    <tr>
      <td>Inferior <font color="blue">internal controls</font>     <font color="blue">could also harm</font> our reputation and cause investors to <font color="blue">lose confidence</font> in our     reported financial information, <font color="blue">which could</font> have a negative <font color="blue">impact on</font> the     <font color="blue">trading price</font> of our stock</td>
    </tr>
    <tr>
      <td>35     ______________________________________________________________________    [56]Table of <font color="blue">Contents       </font>We have <font color="blue"><font color="blue">treatment center</font>s</font> in Florida and other areas that could be disrupted     or <font color="blue">damaged by hurricanes</font></td>
    </tr>
    <tr>
      <td>Florida is susceptible to hurricanes and we currently have 24 radiation     <font color="blue"><font color="blue">treatment center</font>s</font> located in Florida</td>
    </tr>
    <tr>
      <td>Our Florida <font color="blue">centers accounted</font> for     approximately 57prca of our <font color="blue">total revenues</font> during 2005</td>
    </tr>
    <tr>
      <td><font color="blue">Recently </font>21 of our     <font color="blue"><font color="blue">treatment center</font>s</font> in <font color="blue">South Florida </font>were <font color="blue">disrupted by</font> <font color="blue"><font color="blue">Hurricane Wilma</font> </font>which     required us to close all of these centers for a business day</td>
    </tr>
    <tr>
      <td>Although none     of these <font color="blue"><font color="blue">treatment center</font>s</font> suffered structural damage as a result of the     hurricane, their <font color="blue">utility services</font> were disrupted</td>
    </tr>
    <tr>
      <td>Our patients and employees     were <font color="blue">also affected by</font> <font color="blue">Hurricane Wilma</font></td>
    </tr>
    <tr>
      <td>While we do not anticipate that     <font color="blue"><font color="blue">Hurricane Wilma</font> </font>will have any long-term <font color="blue">impact on</font> our business, our <font color="blue">Florida     </font><font color="blue"><font color="blue">treatment center</font>s</font> and any of our other <font color="blue"><font color="blue">treatment center</font>s</font> located in other     areas that are in the path of a <font color="blue">hurricane could</font> be subject to <font color="blue">significant</font>     hurricane-related disruptions and/or damage in the future</td>
    </tr>
    <tr>
      <td>If our treatment     <font color="blue">centers suffer</font> any <font color="blue">significant</font> hurricane-related disruptions and/or damage     in the future it could have an <font color="blue">adverse affect on</font> our business and financial     results</td>
    </tr>
    <tr>
      <td>We carry <font color="blue">property damage</font> and business interruption <font color="blue">insurance on</font> our     <font color="blue">facilities</font>, but there can be no assurance that it would be adequate to cover     all of our hurricane-related losses</td>
    </tr>
    <tr>
      <td>Forward <font color="blue">looking statements</font></td>
    </tr>
    <tr>
      <td>We may make other written and oral     <font color="blue">communications</font>  from  time  to  time  that  contain  such  statements</td>
    </tr>
    <tr>
      <td>Forward-<font color="blue">looking statements</font>, including <font color="blue">statements as</font> to <font color="blue">industry trends</font>,     future  <font color="blue">expectations</font>  and other matters that do not relate strictly to     <font color="blue">historical facts</font> are <font color="blue">based on</font> certain <font color="blue">assumptions</font> by <font color="blue">management</font></td>
    </tr>
    <tr>
      <td><font color="blue">These     </font>statement are often identified by the use of words such as “may,” “will,”     “expect,”   “plans,”  “believe,”  “  anticipate,”  “intend,”  “could,”     “estimate,” or “continue” and similar <font color="blue">expressions</font> or <font color="blue">variations</font>, and are     <font color="blue">based on</font> the beliefs and <font color="blue">assumptions</font> of our <font color="blue">management</font> <font color="blue">based on</font> information     <font color="blue">then currently available</font> to <font color="blue">management</font></td>
    </tr>
    <tr>
      <td>Such forward-<font color="blue">looking statements</font> are     subject to risks, uncertainties and other factors that could cause actual     results to differ <font color="blue">materially</font> from future results expressed or implied by     such forward-<font color="blue">looking statements</font></td>
    </tr>
    <tr>
      <td><font color="blue">Important </font>factors that could cause actual     results to differ <font color="blue">materially</font> from the forward-<font color="blue">looking statements</font> include,     <font color="blue">among others</font>, the <font color="blue">risks discussed herein under</font> the heading “<font color="blue">Risk Factors</font></td>
    </tr>
    <tr>
      <td>”     We  caution  readers to <font color="blue">carefully</font> consider <font color="blue">such factors</font></td>
    </tr>
    <tr>
      <td>Further, such     forward-looking  statements  speak  only  as of the date on which such     statements  are  made  and  we  undertake  <font color="blue">no obligation</font> to update any     forward-looking statement to <font color="blue">reflect events</font> or <font color="blue">circumstances</font> after the date     of <font color="blue">such statements</font></td>
    </tr>
  </tbody>
</table>